{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:50:54Z","timestamp":1777521054260,"version":"3.51.4"},"reference-count":298,"publisher":"Springer Science and Business Media LLC","issue":"20","license":[{"start":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T00:00:00Z","timestamp":1497571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31171211"],"award-info":[{"award-number":["31171211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471305"],"award-info":[{"award-number":["81471305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671260"],"award-info":[{"award-number":["81671260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200983"],"award-info":[{"award-number":["81200983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81301082"],"award-info":[{"award-number":["81301082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00018-017-2549-2","type":"journal-article","created":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T10:14:30Z","timestamp":1497608070000},"page":"3741-3768","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"74","author":[{"given":"Yan","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhicheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinsha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,16]]},"reference":[{"issue":"9423","key":"2549_CR1","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii A, Nutt JG, Ransom BR (2004) Parkinson\u2019s disease. Lancet 363(9423):1783\u20131793. doi: 10.1016\/S0140-6736(04)16305-8","journal-title":"Lancet"},{"issue":"3","key":"2549_CR2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","volume":"59","author":"T Witjas","year":"2002","unstructured":"Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, Poncet M, Cherif AA (2002) Nonmotor fluctuations in Parkinson\u2019s disease: frequent and disabling. Neurology 59(3):408\u2013413","journal-title":"Neurology"},{"issue":"3","key":"2549_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5(3):235\u2013245. doi: 10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"2549_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320. doi: 10.1111\/j.1468-1331.2008.02056.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"2549_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464\u2013474. doi: 10.1016\/S1474-4422(09)70068-7","journal-title":"Lancet Neurol"},{"issue":"5","key":"2549_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.parkreldis.2012.02.002","volume":"18","author":"W Chen","year":"2012","unstructured":"Chen W, Xu ZM, Wang G, Chen SD (2012) Non-motor symptoms of Parkinson\u2019s disease in China: a review of the literature. Parkinsonism Relat Disord 18(5):446\u2013452. doi: 10.1016\/j.parkreldis.2012.02.002","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"2549_CR7","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11910-012-0283-6","volume":"12","author":"CJ Barnum","year":"2012","unstructured":"Barnum CJ, Tansey MG (2012) Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson\u2019s disease? Curr Neurol Neurosci Rep 12(4):350\u2013358. doi: 10.1007\/s11910-012-0283-6","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"2549_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1586\/14737175.2015.1038244","volume":"15","author":"AQ Rana","year":"2015","unstructured":"Rana AQ, Ahmed US, Chaudry ZM, Vasan S (2015) Parkinson\u2019s disease: a review of non-motor symptoms. Expert Rev Neurother 15(5):549\u2013562. doi: 10.1586\/14737175.2015.1038244","journal-title":"Expert Rev Neurother"},{"key":"2549_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jns.2015.11.047","volume":"360","author":"R Ou","year":"2016","unstructured":"Ou R, Yang J, Cao B, Wei Q, Chen K, Chen X, Zhao B, Wu Y, Song W, Shang H (2016) Progression of non-motor symptoms in Parkinson\u2019s disease among different age populations: a two-year follow-up study. J Neurol Sci 360:72\u201377. doi: 10.1016\/j.jns.2015.11.047","journal-title":"J Neurol Sci"},{"key":"2549_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn S (2003) Description of Parkinson\u2019s disease as a clinical syndrome. Ann N Y Acad Sci 991:1\u201314","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"2549_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol 8(4):382\u2013397. doi: 10.1016\/S1474-4422(09)70062-6","journal-title":"Lancet Neurol"},{"issue":"4\u20135","key":"2549_CR12","first-page":"245","volume":"19","author":"GL Willis","year":"2008","unstructured":"Willis GL (2008) Parkinson\u2019s disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 19(4\u20135):245\u2013316","journal-title":"Rev Neurosci"},{"issue":"3","key":"2549_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/biof.159","volume":"37","author":"T Cali","year":"2011","unstructured":"Cali T, Ottolini D, Brini M (2011) Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson\u2019s disease. BioFactors 37(3):228\u2013240. doi: 10.1002\/biof.159","journal-title":"BioFactors"},{"issue":"24 Pt A","key":"2549_CR14","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","volume":"589","author":"D Haddad","year":"2015","unstructured":"Haddad D, Nakamura K (2015) Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease. FEBS letters 589(24 Pt A):3702\u20133713. doi: 10.1016\/j.febslet.2015.10.021","journal-title":"FEBS letters"},{"issue":"5","key":"2549_CR15","doi-asserted-by":"publisher","first-page":"a009423","DOI":"10.1101\/cshperspect.a009423","volume":"2","author":"C Cook","year":"2012","unstructured":"Cook C, Stetler C, Petrucelli L (2012) Disruption of protein quality control in Parkinson\u2019s disease. Cold Spring Harbor Perspect Med 2(5):a009423. doi: 10.1101\/cshperspect.a009423","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"7","key":"2549_CR16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00018-015-2101-1","volume":"73","author":"D Lindholm","year":"2016","unstructured":"Lindholm D, Makela J, Di Liberto V, Mudo G, Belluardo N, Eriksson O, Saarma M (2016) Current disease modifying approaches to treat Parkinson\u2019s disease. Cell Mol Life Sci CMLS 73(7):1365\u20131379. doi: 10.1007\/s00018-015-2101-1","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2549_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.47","author":"E Lauretti","year":"2016","unstructured":"Lauretti E, Di Meco A, Merali S, Pratico D (2016) Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson\u2019s disease. Mol Psychiatry. doi: 10.1038\/mp.2016.47","journal-title":"Mol Psychiatry"},{"key":"2549_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-016-0090-7","volume":"11","author":"M Pinto","year":"2016","unstructured":"Pinto M, Nissanka N, Peralta S, Brambilla R, Diaz F, Moraes CT (2016) Pioglitazone ameliorates the phenotype of a novel Parkinson\u2019s disease mouse model by reducing neuroinflammation. Mol Neurodegener 11:25. doi: 10.1186\/s13024-016-0090-7","journal-title":"Mol Neurodegener"},{"issue":"8","key":"2549_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976. doi: 10.1038\/sj.bjp.0707167","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2549_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76(2):77\u201398. doi: 10.1016\/j.pneurobio.2005.06.004","journal-title":"Prog Neurobiol"},{"issue":"18","key":"2549_CR21","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181c2f07d","volume":"73","author":"RF Pfeiffer","year":"2009","unstructured":"Pfeiffer RF (2009) Neuroinflammation and Parkinson disease: the silent battleground. Neurology 73(18):1434\u20131435. doi: 10.1212\/WNL.0b013e3181c2f07d","journal-title":"Neurology"},{"issue":"Suppl 3","key":"2549_CR22","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","volume":"15","author":"Y Ouchi","year":"2009","unstructured":"Ouchi Y, Yagi S, Yokokura M, Sakamoto M (2009) Neuroinflammation in the living brain of Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl 3):S200\u2013S204. doi: 10.1016\/S1353-8020(09)70814-4","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"2549_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","volume":"37","author":"MG Tansey","year":"2010","unstructured":"Tansey MG, Goldberg MS (2010) Neuroinflammation in Parkinson\u2019s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 37(3):510\u2013518. doi: 10.1016\/j.nbd.2009.11.004","journal-title":"Neurobiol Dis"},{"key":"2549_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2016.04.006","author":"V Joers","year":"2016","unstructured":"Joers V, Tansey MG, Mulas G, Carta AR (2016) Microglial phenotypes in Parkinson\u2019s disease and animal models of the disease. Prog Neurobiol. doi: 10.1016\/j.pneurobio.2016.04.006","journal-title":"Prog Neurobiol"},{"issue":"3","key":"2549_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/cen3.12237","volume":"6","author":"KV Rama Rao","year":"2015","unstructured":"Rama Rao KV, Kielian T (2015) Neuron-astrocyte interactions in neurodegenerative diseases: role of neuroinflammation. Clin Exp Neuroimmunol 6(3):245\u2013263. doi: 10.1111\/cen3.12237","journal-title":"Clin Exp Neuroimmunol"},{"issue":"1","key":"2549_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/mds.25032","volume":"28","author":"EC Hirsch","year":"2013","unstructured":"Hirsch EC, Jenner P, Przedborski S (2013) Pathogenesis of Parkinson\u2019s disease. Mov Disord 28(1):24\u201330. doi: 10.1002\/mds.25032","journal-title":"Mov Disord"},{"issue":"12","key":"2549_CR27","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","volume":"10","author":"A Videnovic","year":"2014","unstructured":"Videnovic A, Lazar AS, Barker RA, Overeem S (2014) \u2018The clocks that time us\u2019\u2014circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 10(12):683\u2013693. doi: 10.1038\/nrneurol.2014.206","journal-title":"Nat Rev Neurol"},{"key":"2549_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnana.2015.00032","volume":"9","author":"MT Herrero","year":"2015","unstructured":"Herrero MT, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson\u2019s disease: role of glucocorticoids. Front Neuroanat 9:32. doi: 10.3389\/fnana.2015.00032","journal-title":"Front Neuroanat"},{"issue":"8","key":"2549_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2165\/11590430-000000000-00000","volume":"41","author":"MS Fragala","year":"2011","unstructured":"Fragala MS, Kraemer WJ, Denegar CR, Maresh CM, Mastro AM, Volek JS (2011) Neuroendocrine-immune interactions and responses to exercise. Sports Med 41(8):621\u2013639. doi: 10.2165\/11590430-000000000-00000","journal-title":"Sports Med"},{"issue":"3","key":"2549_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease\u2014a double-edged sword. Neuron 35(3):419\u2013432","journal-title":"Neuron"},{"issue":"1\u20132","key":"2549_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160(1\u20132):62\u201373. doi: 10.1016\/j.cell.2014.11.047","journal-title":"Cell"},{"issue":"6","key":"2549_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/cc2879","volume":"8","author":"G Beck","year":"2004","unstructured":"Beck G, Brinkkoetter P, Hanusch C, Schulte J, van Ackern K, van der Woude FJ, Yard BA (2004) Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 8(6):485\u2013491. doi: 10.1186\/cc2879","journal-title":"Crit Care"},{"issue":"16","key":"2549_CR33","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.1073\/pnas.0400782101","volume":"101","author":"AI Su","year":"2004","unstructured":"Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101(16):6062\u20136067. doi: 10.1073\/pnas.0400782101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"41","key":"2549_CR34","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","volume":"26","author":"SA Austin","year":"2006","unstructured":"Austin SA, Floden AM, Murphy EJ, Combs CK (2006) Alpha-synuclein expression modulates microglial activation phenotype. J Neurosci 26(41):10558\u201310563. doi: 10.1523\/JNEUROSCI.1799-06.2006","journal-title":"J Neurosci"},{"issue":"11","key":"2549_CR35","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","volume":"10","author":"C Wu","year":"2009","unstructured":"Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW 3rd, Su AI (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10(11):R130. doi: 10.1186\/gb-2009-10-11-r130","journal-title":"Genome Biol"},{"issue":"9","key":"2549_CR36","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1002\/mds.25111","volume":"27","author":"SH Appel","year":"2012","unstructured":"Appel SH (2012) Inflammation in Parkinson\u2019s disease: cause or consequence? Mov Disord 27(9):1075\u20131077. doi: 10.1002\/mds.25111","journal-title":"Mov Disord"},{"issue":"1","key":"2549_CR37","doi-asserted-by":"publisher","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harbor Perspect Med 2(1):a008888. doi: 10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"2549_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldv022","volume":"114","author":"S Mullin","year":"2015","unstructured":"Mullin S, Schapira A (2015) The genetics of Parkinson\u2019s disease. Br Med Bull 114(1):39\u201352. doi: 10.1093\/bmb\/ldv022","journal-title":"Br Med Bull"},{"issue":"R1","key":"2549_CR39","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1093\/hmg\/ddv236","volume":"24","author":"R Kumaran","year":"2015","unstructured":"Kumaran R, Cookson MR (2015) Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson\u2019s disease. Hum Mol Genet 24(R1):R32\u2013R44. doi: 10.1093\/hmg\/ddv236","journal-title":"Hum Mol Genet"},{"key":"2549_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuroscience.2014.10.028","volume":"302","author":"N Dzamko","year":"2015","unstructured":"Dzamko N, Geczy CL, Halliday GM (2015) Inflammation is genetically implicated in Parkinson\u2019s disease. Neuroscience 302:89\u2013102. doi: 10.1016\/j.neuroscience.2014.10.028","journal-title":"Neuroscience"},{"issue":"3","key":"2549_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.molmed.2012.12.003","volume":"19","author":"YM Nolan","year":"2013","unstructured":"Nolan YM, Sullivan AM, Toulouse A (2013) Parkinson\u2019s disease in the nuclear age of neuroinflammation. Trends Mol Med 19(3):187\u2013196. doi: 10.1016\/j.molmed.2012.12.003","journal-title":"Trends Mol Med"},{"issue":"5321","key":"2549_CR42","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276(5321):2045\u20132047","journal-title":"Science"},{"issue":"9440","key":"2549_CR43","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"MC Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, Hulihan M, Waucquier N, Defebvre L, Amouyel P, Farrer M, Destee A (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet 364(9440):1167\u20131169. doi: 10.1016\/S0140-6736(04)17103-1","journal-title":"Lancet"},{"issue":"5646","key":"2549_CR44","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302(5646):841. doi: 10.1126\/science.1090278","journal-title":"Science"},{"issue":"2","key":"2549_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kruger","year":"1998","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18(2):106\u2013108. doi: 10.1038\/ng0298-106","journal-title":"Nat Genet"},{"issue":"2","key":"2549_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, Atares B, Llorens V, Gomez Tortosa E, del Ser T, Munoz DG, de Yebenes JG (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55(2):164\u2013173. doi: 10.1002\/ana.10795","journal-title":"Ann Neurol"},{"issue":"4","key":"2549_CR47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, Bousset L, Honore A, Rozas N, Pieri L, Madiona K, Durr A, Melki R, Verny C, Brice A, French Parkinson\u2019s Disease Genetics Study G (2013) G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459\u2013471. doi: 10.1002\/ana.23894","journal-title":"Ann Neurol"},{"issue":"11","key":"2549_CR48","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","volume":"80","author":"C Proukakis","year":"2013","unstructured":"Proukakis C, Dudzik CG, Brier T, MacKay DS, Cooper JM, Millhauser GL, Houlden H, Schapira AH (2013) A novel alpha-synuclein missense mutation in Parkinson disease. Neurology 80(11):1062\u20131064. doi: 10.1212\/WNL.0b013e31828727ba","journal-title":"Neurology"},{"issue":"6","key":"2549_CR49","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA, Nishioka K, Fuchs J, Gasser T, Maraganore DM, Adler CH, Larvor L, Chartier-Harlin MC, Nilsson C, Langston JW, Gwinn K, Hattori N, Farrer MJ (2008) Genomic investigation of alpha-synuclein multiplication and parkinsonism. Ann Neurol 63(6):743\u2013750. doi: 10.1002\/ana.21380","journal-title":"Ann Neurol"},{"key":"2549_CR50","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1038\/ncomms2534","volume":"4","author":"C Kim","year":"2013","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, Kang J, Joong Lee S, Masliah E, Hwang D, Lee HJ, Lee SJ (2013) Neuron-released oligomeric alpha-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun 4:1562. doi: 10.1038\/ncomms2534","journal-title":"Nat Commun"},{"issue":"3","key":"2549_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 61(3):349\u2013360. doi: 10.1002\/glia.22437","journal-title":"Glia"},{"issue":"6","key":"2549_CR52","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s11064-011-0439-9","volume":"36","author":"SA Austin","year":"2011","unstructured":"Austin SA, Rojanathammanee L, Golovko MY, Murphy EJ, Combs CK (2011) Lack of alpha-synuclein modulates microglial phenotype in vitro. Neurochem Res 36(6):994\u20131004. doi: 10.1007\/s11064-011-0439-9","journal-title":"Neurochem Res"},{"issue":"4","key":"2549_CR53","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/cmi.2010.10","volume":"7","author":"D Zhang","year":"2010","unstructured":"Zhang D, Lin J, Han J (2010) Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol 7(4):243\u2013249. doi: 10.1038\/cmi.2010.10","journal-title":"Cell Mol Immunol"},{"key":"2549_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-2094-11-52","volume":"11","author":"I Russo","year":"2014","unstructured":"Russo I, Bubacco L, Greggio E (2014) LRRK2 and neuroinflammation: partners in crime in Parkinson\u2019s disease? J Neuroinflamm 11:52. doi: 10.1186\/1742-2094-11-52","journal-title":"J Neuroinflamm"},{"issue":"27","key":"2549_CR55","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1056\/NEJMoa0903753","volume":"361","author":"FR Zhang","year":"2009","unstructured":"Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, Cui Y, Yan XX, Yang HT, Yang RD, Chu TS, Zhang C, Zhang L, Han JW, Yu GQ, Quan C, Yu YX, Zhang Z, Shi BQ, Zhang LH, Cheng H, Wang CY, Lin Y, Zheng HF, Fu XA, Zuo XB, Wang Q, Long H, Sun YP, Cheng YL, Tian HQ, Zhou FS, Liu HX, Lu WS, He SM, Du WL, Shen M, Jin QY, Wang Y, Low HQ, Erwin T, Yang NH, Li JY, Zhao X, Jiao YL, Mao LG, Yin G, Jiang ZX, Wang XD, Yu JP, Hu ZH, Gong CH, Liu YQ, Liu RY, Wang DM, Wei D, Liu JX, Cao WK, Cao HZ, Li YP, Yan WG, Wei SY, Wang KJ, Hibberd ML, Yang S, Zhang XJ, Liu JJ (2009) Genomewide association study of leprosy. N Engl J Med 361(27):2609\u20132618. doi: 10.1056\/NEJMoa0903753","journal-title":"N Engl J Med"},{"issue":"8","key":"2549_CR56","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/ng.175","volume":"40","author":"JC Barrett","year":"2008","unstructured":"Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, Datta LW, Green T, Griffiths AM, Kistner EO, Murtha MT, Regueiro MD, Rotter JI, Schumm LP, Steinhart AH, Targan SR, Xavier RJ, Consortium NIG, Libioulle C, Sandor C, Lathrop M, Belaiche J, Dewit O, Gut I, Heath S, Laukens D, Mni M, Rutgeerts P, Van Gossum A, Zelenika D, Franchimont D, Hugot JP, de Vos M, Vermeire S, Louis E, Belgian-French IBDC, Wellcome Trust Case Control C, Cardon LR, Anderson CA, Drummond H, Nimmo E, Ahmad T, Prescott NJ, Onnie CM, Fisher SA, Marchini J, Ghori J, Bumpstead S, Gwilliam R, Tremelling M, Deloukas P, Mansfield J, Jewell D, Satsangi J, Mathew CG, Parkes M, Georges M, Daly MJ (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease. Nat Genet 40(8):955\u2013962. doi: 10.1038\/ng.175","journal-title":"Nat Genet"},{"issue":"12","key":"2549_CR57","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1002\/ibd.21651","volume":"17","author":"J Umeno","year":"2011","unstructured":"Umeno J, Asano K, Matsushita T, Matsumoto T, Kiyohara Y, Iida M, Nakamura Y, Kamatani N, Kubo M (2011) Meta-analysis of published studies identified eight additional common susceptibility loci for Crohn\u2019s disease and ulcerative colitis. Inflamm Bowel Dis 17(12):2407\u20132415. doi: 10.1002\/ibd.21651","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 1","key":"2549_CR58","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/S1353-8020(11)70004-9","volume":"18","author":"V Bonifati","year":"2012","unstructured":"Bonifati V (2012) Autosomal recessive parkinsonism. Parkinsonism Relat Disord 18(Suppl 1):S4\u2013S6. doi: 10.1016\/S1353-8020(11)70004-9","journal-title":"Parkinsonism Relat Disord"},{"issue":"44","key":"2549_CR59","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","volume":"278","author":"MS Goldberg","year":"2003","unstructured":"Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, Shen J (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278(44):43628\u201343635. doi: 10.1074\/jbc.M308947200","journal-title":"J Biol Chem"},{"issue":"43","key":"2549_CR60","doi-asserted-by":"publisher","first-page":"10825","DOI":"10.1523\/JNEUROSCI.3001-08.2008","volume":"28","author":"TC Frank-Cannon","year":"2008","unstructured":"Frank-Cannon TC, Tran T, Ruhn KA, Martinez TN, Hong J, Marvin M, Hartley M, Trevino I, O\u2019Brien DE, Casey B, Goldberg MS, Tansey MG (2008) Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J Neurosci 28(43):10825\u201310834. doi: 10.1523\/JNEUROSCI.3001-08.2008","journal-title":"J Neurosci"},{"issue":"2","key":"2549_CR61","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cell.2016.05.039","volume":"166","author":"D Matheoud","year":"2016","unstructured":"Matheoud D, Sugiura A, Bellemare-Pelletier A, Laplante A, Rondeau C, Chemali M, Fazel A, Bergeron JJ, Trudeau LE, Burelle Y, Gagnon E, McBride HM, Desjardins M (2016) Parkinson\u2019s disease-related proteins PINK1 and Parkin repress mitochondrial antigen presentation. Cell 166(2):314\u2013327. doi: 10.1016\/j.cell.2016.05.039","journal-title":"Cell"},{"key":"2549_CR62","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","volume":"5","author":"C Cebrian","year":"2014","unstructured":"Cebrian C, Zucca FA, Mauri P, Steinbeck JA, Studer L, Scherzer CR, Kanter E, Budhu S, Mandelbaum J, Vonsattel JP, Zecca L, Loike JD, Sulzer D (2014) MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun 5:3633. doi: 10.1038\/ncomms4633","journal-title":"Nat Commun"},{"issue":"1\u20134","key":"2549_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000332803","volume":"10","author":"C Alves da Costa","year":"2012","unstructured":"Alves da Costa C, Checler F (2012) Parkin: much more than a simple ubiquitin ligase. Neuro-degener Dis 10(1\u20134):49\u201351. doi: 10.1159\/000332803","journal-title":"Neuro-degener Dis"},{"key":"2549_CR64","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1750-1326-8-29","volume":"8","author":"CR Sunico","year":"2013","unstructured":"Sunico CR, Nakamura T, Rockenstein E, Mante M, Adame A, Chan SF, Newmeyer TF, Masliah E, Nakanishi N, Lipton SA (2013) S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson\u2019s disease. Mol Neurodegener 8:29. doi: 10.1186\/1750-1326-8-29","journal-title":"Mol Neurodegener"},{"issue":"10","key":"2549_CR65","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1080\/10715760500260348","volume":"39","author":"HM Li","year":"2005","unstructured":"Li HM, Niki T, Taira T, Iguchi-Ariga SM, Ariga H (2005) Association of DJ-1 with chaperones and enhanced association and colocalization with mitochondrial Hsp70 by oxidative stress. Free Radic Res 39(10):1091\u20131099. doi: 10.1080\/10715760500260348","journal-title":"Free Radic Res"},{"issue":"4","key":"2549_CR66","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","volume":"45","author":"MS Goldberg","year":"2005","unstructured":"Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, Costa C, Tong Y, Martella G, Tscherter A, Martins A, Bernardi G, Roth BL, Pothos EN, Calabresi P, Shen J (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron 45(4):489\u2013496. doi: 10.1016\/j.neuron.2005.01.041","journal-title":"Neuron"},{"issue":"24","key":"2549_CR67","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.1073\/pnas.0402959101","volume":"101","author":"RM Canet-Aviles","year":"2004","unstructured":"Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista MJ, Ringe D, Petsko GA, Cookson MR (2004) The Parkinson\u2019s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci USA 101(24):9103\u20139108. doi: 10.1073\/pnas.0402959101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"29","key":"2549_CR68","doi-asserted-by":"publisher","first-page":"10244","DOI":"10.1073\/pnas.0708518105","volume":"105","author":"MP Brug van der","year":"2008","unstructured":"van der Brug MP, Blackinton J, Chandran J, Hao LY, Lal A, Mazan-Mamczarz K, Martindale J, Xie C, Ahmad R, Thomas KJ, Beilina A, Gibbs JR, Ding J, Myers AJ, Zhan M, Cai H, Bonini NM, Gorospe M, Cookson MR (2008) RNA binding activity of the recessive parkinsonism protein DJ-1 supports involvement in multiple cellular pathways. Proc Natl Acad Sci USA 105(29):10244\u201310249. doi: 10.1073\/pnas.0708518105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"2549_CR69","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1073\/pnas.0501282102","volume":"102","author":"RH Kim","year":"2005","unstructured":"Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, Pownall S, Wakeham A, You-Ten AJ, Kalia SK, Horne P, Westaway D, Lozano AM, Anisman H, Park DS, Mak TW (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102(14):5215\u20135220. doi: 10.1073\/pnas.0501282102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"2549_CR70","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1093\/hmg\/ddm249","volume":"16","author":"W Yang","year":"2007","unstructured":"Yang W, Chen L, Ding Y, Zhuang X, Kang UJ (2007) Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice. Hum Mol Genet 16(23):2900\u20132910. doi: 10.1093\/hmg\/ddm249","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2549_CR71","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1371\/journal.pbio.0020327","volume":"2","author":"C Martinat","year":"2004","unstructured":"Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism. PLoS Biol 2(11):e327. doi: 10.1371\/journal.pbio.0020327","journal-title":"PLoS Biol"},{"issue":"8","key":"2549_CR72","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1096\/fj.08-125153","volume":"23","author":"J Waak","year":"2009","unstructured":"Waak J, Weber SS, Waldenmaier A, Gorner K, Alunni-Fabbroni M, Schell H, Vogt-Weisenhorn D, Pham TT, Reumers V, Baekelandt V, Wurst W, Kahle PJ (2009) Regulation of astrocyte inflammatory responses by the Parkinson\u2019s disease-associated gene DJ-1. FASEB J 23(8):2478\u20132489. doi: 10.1096\/fj.08-125153","journal-title":"FASEB J"},{"issue":"10","key":"2549_CR73","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38(10):1184\u20131191. doi: 10.1038\/ng1884","journal-title":"Nat Genet"},{"issue":"12","key":"2549_CR74","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","volume":"32","author":"M Usenovic","year":"2012","unstructured":"Usenovic M, Tresse E, Mazzulli JR, Taylor JP, Krainc D (2012) Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J Neurosci 32(12):4240\u20134246. doi: 10.1523\/JNEUROSCI.5575-11.2012","journal-title":"J Neurosci"},{"issue":"22","key":"2549_CR75","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00018-013-1352-y","volume":"70","author":"M Deleidi","year":"2013","unstructured":"Deleidi M, Gasser T (2013) The role of inflammation in sporadic and familial Parkinson\u2019s disease. Cell Mol Life Sci CMLS 70(22):4259\u20134273. doi: 10.1007\/s00018-013-1352-y","journal-title":"Cell Mol Life Sci CMLS"},{"key":"2549_CR76","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 4:19. doi: 10.1186\/s40035-015-0042-0","journal-title":"Transl Neurodegener"},{"key":"2549_CR77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137\u2013161. doi: 10.1146\/annurev-cellbio-101011-155745","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"2549_CR78","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/cns.12514","volume":"22","author":"C Qiao","year":"2016","unstructured":"Qiao C, Yin N, Gu HY, Zhu JL, Ding JH, Lu M, Hu G (2016) Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation. CNS Neurosci Ther 22(6):451\u2013460. doi: 10.1111\/cns.12514","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"2549_CR79","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/cns.12536","volume":"22","author":"J Dong","year":"2016","unstructured":"Dong J, Li S, Mo JL, Cai HB, Le WD (2016) Nurr1-based therapies for Parkinson\u2019s Disease. CNS Neurosci Ther 22(5):351\u2013359. doi: 10.1111\/cns.12536","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"2549_CR80","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000204229","volume":"16","author":"X Fan","year":"2009","unstructured":"Fan X, Luo G, Ming M, Pu P, Li L, Yang D, Le W (2009) Nurr1 expression and its modulation in microglia. NeuroImmunoModulation 16(3):162\u2013170. doi: 10.1159\/000204229","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"2549_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","volume":"137","author":"K Saijo","year":"2009","unstructured":"Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK (2009) A Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137(1):47\u201359. doi: 10.1016\/j.cell.2009.01.038","journal-title":"Cell"},{"issue":"4","key":"2549_CR82","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.neuint.2010.01.005","volume":"56","author":"H No","year":"2010","unstructured":"No H, Bang Y, Lim J, Kim SS, Choi HS, Choi HJ (2010) Involvement of induction and mitochondrial targeting of orphan nuclear receptor Nur77 in 6-OHDA-induced SH-SY5Y cell death. Neurochem Int 56(4):620\u2013626. doi: 10.1016\/j.neuint.2010.01.005","journal-title":"Neurochem Int"},{"issue":"9","key":"2549_CR83","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1007\/s12035-015-9477-7","volume":"53","author":"X Wei","year":"2016","unstructured":"Wei X, Gao H, Zou J, Liu X, Chen D, Liao J, Xu Y, Ma L, Tang B, Zhang Z, Cai X, Jin K, Xia Y, Wang Q (2016) Contra-directional coupling of Nur77 and Nurr1 in neurodegeneration: a novel mechanism for memantine-induced anti-inflammation and anti-mitochondrial impairment. Mol Neurobiol 53(9):5876\u20135892. doi: 10.1007\/s12035-015-9477-7","journal-title":"Mol Neurobiol"},{"issue":"2\u20135","key":"2549_CR84","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0960-0760(03)00214-0","volume":"85","author":"C Blanquart","year":"2003","unstructured":"Blanquart C, Barbier O, Fruchart JC, Staels B, Glineur C (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J Steroid Biochem Mol Biol 85(2\u20135):267\u2013273","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"10","key":"2549_CR85","doi-asserted-by":"publisher","first-page":"e76820","DOI":"10.1371\/journal.pone.0076820","volume":"8","author":"MH Park","year":"2013","unstructured":"Park MH, Park JY, Lee HJ, Kim DH, Chung KW, Park D, Jeong HO, Kim HR, Park CH, Kim SR, Chun P, Byun Y, Moon HR, Chung HY (2013) The novel PPAR alpha\/gamma dual agonist MHY 966 modulates UVB-induced skin inflammation by inhibiting NF-kappaB activity. PLoS One 8(10):e76820. doi: 10.1371\/journal.pone.0076820","journal-title":"PLoS One"},{"issue":"1","key":"2549_CR86","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","volume":"46","author":"YC Chen","year":"2012","unstructured":"Chen YC, Wu JS, Tsai HD, Huang CY, Chen JJ, Sun GY, Lin TN (2012) Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and neurodegenerative disorders. Mol Neurobiol 46(1):114\u2013124. doi: 10.1007\/s12035-012-8259-8","journal-title":"Mol Neurobiol"},{"key":"2549_CR87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1742-2094-8-91","volume":"8","author":"CR Swanson","year":"2011","unstructured":"Swanson CR, Joers V, Bondarenko V, Brunner K, Simmons HA, Ziegler TE, Kemnitz JW, Johnson JA, Emborg ME (2011) The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflamm 8:91. doi: 10.1186\/1742-2094-8-91","journal-title":"J Neuroinflamm"},{"issue":"7","key":"2549_CR88","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/1389450111314070004","volume":"14","author":"AR Carta","year":"2013","unstructured":"Carta AR (2013) PPAR-gamma: therapeutic prospects in Parkinson\u2019s disease. Curr Drug Targets 14(7):743\u2013751","journal-title":"Curr Drug Targets"},{"key":"2549_CR89","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.nbd.2014.08.011","volume":"71","author":"A Pisanu","year":"2014","unstructured":"Pisanu A, Lecca D, Mulas G, Wardas J, Simbula G, Spiga S, Carta AR (2014) Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-gamma agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson\u2019s disease. Neurobiol Dis 71:280\u2013291. doi: 10.1016\/j.nbd.2014.08.011","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2549_CR90","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1124\/jpet.106.115758","volume":"320","author":"A Iwashita","year":"2007","unstructured":"Iwashita A, Muramatsu Y, Yamazaki T, Muramoto M, Kita Y, Yamazaki S, Mihara K, Moriguchi A, Matsuoka N (2007) Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo. J Pharmacol Exp Ther 320(3):1087\u20131096. doi: 10.1124\/jpet.106.115758","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2549_CR91","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brainres.2006.12.011","volume":"1135","author":"A Kreisler","year":"2007","unstructured":"Kreisler A, Gele P, Wiart JF, Lhermitte M, Destee A, Bordet R (2007) Lipid-lowering drugs in the MPTP mouse model of Parkinson\u2019s disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not. Brain Res 1135(1):77\u201384. doi: 10.1016\/j.brainres.2006.12.011","journal-title":"Brain Res"},{"key":"2549_CR92","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pnpbp.2014.02.009","volume":"53","author":"JK Barbiero","year":"2014","unstructured":"Barbiero JK, Santiago R, Tonin FS, Boschen S, da Silva LM, Werner MF, da Cunha C, Lima MM, Vital MA (2014) PPAR-alpha agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 53:35\u201344. doi: 10.1016\/j.pnpbp.2014.02.009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"2549_CR93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1567202611666140318114037","volume":"11","author":"NR Das","year":"2014","unstructured":"Das NR, Gangwal RP, Damre MV, Sangamwar AT, Sharma SS (2014) A PPAR-beta\/delta agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson\u2019s disease. Curr Neurovasc Res 11(2):114\u2013124","journal-title":"Curr Neurovasc Res"},{"issue":"3","key":"2549_CR94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-0102(96)01105-4","volume":"26","author":"M Morimoto","year":"1996","unstructured":"Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M (1996) Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci Res 26(3):235\u2013269","journal-title":"Neurosci Res"},{"issue":"16","key":"2549_CR95","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1073\/pnas.1017820108","volume":"108","author":"F Ros-Bernal","year":"2011","unstructured":"Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L, Alvarez-Fischer D, Carrillo-de Sauvage MA, Saurini F, Coussieu C, Kinugawa K, Prigent A, Hoglinger G, Hamon M, Tronche F, Hirsch EC, Vyas S (2011) Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci USA 108(16):6632\u20136637. doi: 10.1073\/pnas.1017820108","journal-title":"Proc Natl Acad Sci USA"},{"key":"2549_CR96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1749-6632.2012.06633.x","volume":"1261","author":"MN Silverman","year":"2012","unstructured":"Silverman MN, Sternberg EM (2012) Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci 1261:55\u201363. doi: 10.1111\/j.1749-6632.2012.06633.x","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2549_CR97","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/mp.2012.144","volume":"18","author":"F Lamers","year":"2013","unstructured":"Lamers F, Vogelzangs N, Merikangas KR, de Jonge P, Beekman AT, Penninx BW (2013) Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression. Mol Psychiatry 18(6):692\u2013699. doi: 10.1038\/mp.2012.144","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2549_CR98","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1471-4159.2002.00799.x","volume":"81","author":"A Castano","year":"2002","unstructured":"Castano A, Herrera AJ, Cano J, Machado A (2002) The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem 81(1):150\u2013157","journal-title":"J Neurochem"},{"issue":"10\u201311","key":"2549_CR99","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.intimp.2004.05.006","volume":"4","author":"I Kurkowska-Jastrzebska","year":"2004","unstructured":"Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybylkowski A, Czlonkowski A, Czlonkowska A (2004) Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson\u2019s disease. Int Immunopharmacol 4(10\u201311):1307\u20131318. doi: 10.1016\/j.intimp.2004.05.006","journal-title":"Int Immunopharmacol"},{"issue":"13","key":"2549_CR100","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1523\/JNEUROSCI.23-13-05536.2003","volume":"23","author":"S Nadeau","year":"2003","unstructured":"Nadeau S, Rivest S (2003) Glucocorticoids play a fundamental role in protecting the brain during innate immune response. J Neurosci 23(13):5536\u20135544","journal-title":"J Neurosci"},{"issue":"Pt A","key":"2549_CR101","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.09.040","volume":"155","author":"XC Sun","year":"2016","unstructured":"Sun XC, Ren XF, Chen L, Gao XQ, Xie JX, Chen WF (2016) Glucocorticoid receptor is involved in the neuroprotective effect of ginsenoside Rg1 against inflammation-induced dopaminergic neuronal degeneration in substantia nigra. J Steroid Biochem Mol Biol 155(Pt A):94\u2013103. doi: 10.1016\/j.jsbmb.2015.09.040","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"8","key":"2549_CR102","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.bbadis.2010.10.007","volume":"1812","author":"V Duong","year":"2011","unstructured":"Duong V, Rochette-Egly C (2011) The molecular physiology of nuclear retinoic acid receptors. From health to disease. Biochem Biophys Acta 1812(8):1023\u20131031. doi: 10.1016\/j.bbadis.2010.10.007","journal-title":"Biochem Biophys Acta"},{"issue":"10","key":"2549_CR103","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrn2212","volume":"8","author":"M Maden","year":"2007","unstructured":"Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8(10):755\u2013765. doi: 10.1038\/nrn2212","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2549_CR104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/glia.20153","volume":"50","author":"ST Dheen","year":"2005","unstructured":"Dheen ST, Jun Y, Yan Z, Tay SS, Ling EA (2005) Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia 50(1):21\u201331. doi: 10.1002\/glia.20153","journal-title":"Glia"},{"issue":"6","key":"2549_CR105","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140(6):918\u2013934. doi: 10.1016\/j.cell.2010.02.016","journal-title":"Cell"},{"issue":"3","key":"2549_CR106","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s004010000284","volume":"101","author":"M Mittelbronn","year":"2001","unstructured":"Mittelbronn M, Dietz K, Schluesener HJ, Meyermann R (2001) Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol 101(3):249\u2013255","journal-title":"Acta Neuropathol"},{"issue":"16","key":"2549_CR107","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","volume":"20","author":"WG Kim","year":"2000","unstructured":"Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20(16):6309\u20136316","journal-title":"J Neurosci"},{"issue":"1","key":"2549_CR108","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57\u201369. doi: 10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"2549_CR109","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, Wilson B, Zhang W, Zhou Y, Hong JS, Zhang J (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. FASEB J 19(6):533\u2013542. doi: 10.1096\/fj.04-2751com","journal-title":"FASEB J"},{"issue":"10","key":"2549_CR110","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.1007\/s12035-015-9593-4","volume":"53","author":"L Xu","year":"2016","unstructured":"Xu L, He D, Bai Y (2016) Microglia-mediated inflammation and neurodegenerative disease. Mol Neurobiol 53(10):6709\u20136715. doi: 10.1007\/s12035-015-9593-4","journal-title":"Mol Neurobiol"},{"issue":"4","key":"2549_CR111","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124(4):783\u2013801. doi: 10.1016\/j.cell.2006.02.015","journal-title":"Cell"},{"issue":"5","key":"2549_CR112","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT (2007) Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55(5):453\u2013462. doi: 10.1002\/glia.20467","journal-title":"Glia"},{"issue":"1","key":"2549_CR113","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2010.09.005","volume":"41","author":"MA Burguillos","year":"2011","unstructured":"Burguillos MA, Hajji N, Englund E, Persson A, Cenci AM, Machado A, Cano J, Joseph B, Venero JL (2011) Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson\u2019s disease patients. Neurobiol Dis 41(1):177\u2013188. doi: 10.1016\/j.nbd.2010.09.005","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2549_CR114","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2012.10.001","volume":"27","author":"DB Hoban","year":"2013","unstructured":"Hoban DB, Connaughton E, Connaughton C, Hogan G, Thornton C, Mulcahy P, Moloney TC, Dowd E (2013) Further characterisation of the LPS model of Parkinson\u2019s disease: a comparison of intra-nigral and intra-striatal lipopolysaccharide administration on motor function, microgliosis and nigrostriatal neurodegeneration in the rat. Brain Behav Immun 27(1):91\u2013100. doi: 10.1016\/j.bbi.2012.10.001","journal-title":"Brain Behav Immun"},{"issue":"6","key":"2549_CR115","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/glia.22479","volume":"61","author":"L Qin","year":"2013","unstructured":"Qin L, Liu Y, Hong JS, Crews FT (2013) NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 61(6):855\u2013868. doi: 10.1002\/glia.22479","journal-title":"Glia"},{"issue":"3","key":"2549_CR116","doi-asserted-by":"publisher","first-page":"e0151569","DOI":"10.1371\/journal.pone.0151569","volume":"11","author":"CH Chien","year":"2016","unstructured":"Chien CH, Lee MJ, Liou HC, Liou HH, Fu WM (2016) Microglia-derived Cytokines\/Chemokines are involved in the enhancement of LPS-induced loss of nigrostriatal dopaminergic neurons in DJ-1 knockout mice. PLoS One 11(3):e0151569. doi: 10.1371\/journal.pone.0151569","journal-title":"PLoS One"},{"issue":"5\u20136","key":"2549_CR117","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1089\/ars.2005.7.654","volume":"7","author":"XF Wu","year":"2005","unstructured":"Wu XF, Block ML, Zhang W, Qin L, Wilson B, Zhang WQ, Veronesi B, Hong JS (2005) The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid Redox Signal 7(5\u20136):654\u2013661. doi: 10.1089\/ars.2005.7.654","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"2549_CR118","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.neurobiolaging.2011.02.016","volume":"33","author":"EN Mangano","year":"2012","unstructured":"Mangano EN, Litteljohn D, So R, Nelson E, Peters S, Bethune C, Bobyn J, Hayley S (2012) Interferon-gamma plays a role in paraquat-induced neurodegeneration involving oxidative and proinflammatory pathways. Neurobiol Aging 33(7):1411\u20131426. doi: 10.1016\/j.neurobiolaging.2011.02.016","journal-title":"Neurobiol Aging"},{"issue":"2","key":"2549_CR119","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2006.10.008","volume":"25","author":"MG Purisai","year":"2007","unstructured":"Purisai MG, McCormack AL, Cumine S, Li J, Isla MZ, Di Monte DA (2007) Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol Dis 25(2):392\u2013400. doi: 10.1016\/j.nbd.2006.10.008","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2549_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.02.032","volume":"1084","author":"HM Gibbons","year":"2006","unstructured":"Gibbons HM, Dragunow M (2006) Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 1084(1):1\u201315. doi: 10.1016\/j.brainres.2006.02.032","journal-title":"Brain Res"},{"issue":"21","key":"2549_CR121","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1523\/JNEUROSCI.21-21-08447.2001","volume":"21","author":"W Le","year":"2001","unstructured":"Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH (2001) Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson\u2019s disease. J Neurosci 21(21):8447\u20138455","journal-title":"J Neurosci"},{"issue":"5","key":"2549_CR122","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/jnr.20315","volume":"78","author":"R Li","year":"2004","unstructured":"Li R, Huang YG, Fang D, Le WD (2004) (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 78(5):723\u2013731. doi: 10.1002\/jnr.20315","journal-title":"J Neurosci Res"},{"issue":"5","key":"2549_CR123","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1007\/s12035-015-9267-2","volume":"53","author":"N Sharma","year":"2016","unstructured":"Sharma N, Nehru B (2016) Apocyanin, a microglial NADPH oxidase inhibitor prevents dopaminergic neuronal degeneration in lipopolysaccharide-induced Parkinson\u2019s disease model. Mol Neurobiol 53(5):3326\u20133337. doi: 10.1007\/s12035-015-9267-2","journal-title":"Mol Neurobiol"},{"key":"2549_CR124","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1742-2094-11-47","volume":"11","author":"RP Liu","year":"2014","unstructured":"Liu RP, Zou M, Wang JY, Zhu JJ, Lai JM, Zhou LL, Chen SF, Zhang X, Zhu JH (2014) Paroxetine ameliorates lipopolysaccharide-induced microglia activation via differential regulation of MAPK signaling. J Neuroinflamm 11:47. doi: 10.1186\/1742-2094-11-47","journal-title":"J Neuroinflamm"},{"key":"2549_CR125","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbi.2013.11.014","volume":"38","author":"ME Radler","year":"2014","unstructured":"Radler ME, Hale MW, Kent S (2014) Calorie restriction attenuates lipopolysaccharide (LPS)-induced microglial activation in discrete regions of the hypothalamus and the subfornical organ. Brain Behav Immun 38:13\u201324. doi: 10.1016\/j.bbi.2013.11.014","journal-title":"Brain Behav Immun"},{"issue":"6","key":"2549_CR126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-0082(98)00069-0","volume":"57","author":"WJ Streit","year":"1999","unstructured":"Streit WJ, Walter SA, Pennell NA (1999) Reactive microgliosis. Prog Neurobiol 57(6):563\u2013581","journal-title":"Prog Neurobiol"},{"issue":"8","key":"2549_CR127","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol 29(8):357\u2013365. doi: 10.1016\/j.it.2008.05.002","journal-title":"Trends Immunol"},{"issue":"8","key":"2549_CR128","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.25.945","volume":"25","author":"Y Nakamura","year":"2002","unstructured":"Nakamura Y (2002) Regulating factors for microglial activation. Biol Pharm Bull 25(8):945\u2013953","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"2549_CR129","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1523\/JNEUROSCI.19-05-01708.1999","volume":"19","author":"PE Batchelor","year":"1999","unstructured":"Batchelor PE, Liberatore GT, Wong JY, Porritt MJ, Frerichs F, Donnan GA, Howells DW (1999) Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci 19(5):1708\u20131716","journal-title":"J Neurosci"},{"issue":"1","key":"2549_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"B Liu","year":"2003","unstructured":"Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304(1):1\u20137. doi: 10.1124\/jpet.102.035048","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 3","key":"2549_CR131","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1093\/brain\/awp333","volume":"133","author":"S Levesque","year":"2010","unstructured":"Levesque S, Wilson B, Gregoria V, Thorpe LB, Dallas S, Polikov VS, Hong JS, Block ML (2010) Reactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity. Brain J Neurol 133(Pt 3):808\u2013821. doi: 10.1093\/brain\/awp333","journal-title":"Brain J Neurol"},{"issue":"7","key":"2549_CR132","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1096\/fj.05-5053com","volume":"20","author":"T Wang","year":"2006","unstructured":"Wang T, Zhang W, Pei Z, Block M, Wilson B, Reece JM, Miller DS, Hong JS (2006) Reactive microgliosis participates in MPP+-induced dopaminergic neurodegeneration: role of 67\u00a0kDa laminin receptor. FASEB J 20(7):906\u2013915. doi: 10.1096\/fj.05-5053com","journal-title":"FASEB J"},{"issue":"10","key":"2549_CR133","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.4049\/jimmunol.181.10.7194","volume":"181","author":"X Hu","year":"2008","unstructured":"Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H, Liu Y, Qian L, Wilson B, Di Monte DA, Ali SF, Zhang J, Block ML, Hong JS (2008) Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. J Immunol 181(10):7194\u20137204","journal-title":"J Immunol"},{"key":"2549_CR134","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coph.2015.10.001","volume":"26","author":"SH Chen","year":"2016","unstructured":"Chen SH, Oyarzabal EA, Hong JS (2016) Critical role of the Mac1\/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. Curr Opin Pharmacol 26:54\u201360. doi: 10.1016\/j.coph.2015.10.001","journal-title":"Curr Opin Pharmacol"},{"issue":"6","key":"2549_CR135","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39(6):889\u2013909","journal-title":"Neuron"},{"issue":"4587","key":"2549_CR136","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston JW, Ballard P, Tetrud JW, Irwin I (1983) Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219(4587):979\u2013980","journal-title":"Science"},{"issue":"3","key":"2549_CR137","first-page":"257","volume":"4","author":"V Jackson-Lewis","year":"1995","unstructured":"Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995) Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegener J Neurodegener Disord Neuroprot Neuroregener 4(3):257\u2013269","journal-title":"Neurodegener J Neurodegener Disord Neuroprot Neuroregener"},{"issue":"4","key":"2549_CR138","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"JW Langston","year":"1999","unstructured":"Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46(4):598\u2013605","journal-title":"Ann Neurol"},{"issue":"5","key":"2549_CR139","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D (2003) Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 54(5):599\u2013604. doi: 10.1002\/ana.10728","journal-title":"Ann Neurol"},{"issue":"25","key":"2549_CR140","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98(25):14669\u201314674. doi: 10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2549_CR141","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002","volume":"22","author":"DC Wu","year":"2002","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22(5):1763\u20131771","journal-title":"J Neurosci"},{"issue":"45","key":"2549_CR142","doi-asserted-by":"publisher","first-page":"11644","DOI":"10.1523\/JNEUROSCI.3447-06.2006","volume":"26","author":"J Peng","year":"2006","unstructured":"Peng J, Xie L, Stevenson FF, Melov S, Di Monte DA, Andersen JK (2006) Nigrostriatal dopaminergic neurodegeneration in the weaver mouse is mediated via neuroinflammation and alleviated by minocycline administration. J Neurosci 26(45):11644\u201311651. doi: 10.1523\/JNEUROSCI.3447-06.2006","journal-title":"J Neurosci"},{"issue":"15","key":"2549_CR143","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1523\/JNEUROSCI.23-15-06181.2003","volume":"23","author":"HM Gao","year":"2003","unstructured":"Gao HM, Liu B, Hong JS (2003) Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 23(15):6181\u20136187","journal-title":"J Neurosci"},{"issue":"20","key":"2549_CR144","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1111\/febs.12401","volume":"280","author":"JV Emmrich","year":"2013","unstructured":"Emmrich JV, Hornik TC, Neher JJ, Brown GC (2013) Rotenone induces neuronal death by microglial phagocytosis of neurons. FEBS J 280(20):5030\u20135038. doi: 10.1111\/febs.12401","journal-title":"FEBS J"},{"issue":"1","key":"2549_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2009.06.065","volume":"462","author":"H Klintworth","year":"2009","unstructured":"Klintworth H, Garden G, Xia Z (2009) Rotenone and paraquat do not directly activate microglia or induce inflammatory cytokine release. Neurosci Lett 462(1):1\u20135. doi: 10.1016\/j.neulet.2009.06.065","journal-title":"Neurosci Lett"},{"issue":"11","key":"2549_CR146","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1172\/JCI119807","volume":"100","author":"EM Sternberg","year":"1997","unstructured":"Sternberg EM (1997) Neural-immune interactions in health and disease. J Clin Investig 100(11):2641\u20132647. doi: 10.1172\/JCI119807","journal-title":"J Clin Investig"},{"issue":"4","key":"2549_CR147","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1172\/JCI33125","volume":"118","author":"D Chakroborty","year":"2008","unstructured":"Chakroborty D, Chowdhury UR, Sarkar C, Baral R, Dasgupta PS, Basu S (2008) Dopamine regulates endothelial progenitor cell mobilization from mouse bone marrow in tumor vascularization. J Clin Investig 118(4):1380\u20131389. doi: 10.1172\/JCI33125","journal-title":"J Clin Investig"},{"issue":"4","key":"2549_CR148","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","volume":"24","author":"C Sarkar","year":"2010","unstructured":"Sarkar C, Basu B, Chakroborty D, Dasgupta PS, Basu S (2010) The immunoregulatory role of dopamine: an update. Brain Behav Immun 24(4):525\u2013528. doi: 10.1016\/j.bbi.2009.10.015","journal-title":"Brain Behav Immun"},{"issue":"1\u20132","key":"2549_CR149","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0165-5728(02)00280-1","volume":"132","author":"F McKenna","year":"2002","unstructured":"McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, Moots RJ (2002) Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 132(1\u20132):34\u201340","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2549_CR150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78(1):189\u2013225","journal-title":"Physiol Rev"},{"issue":"3","key":"2549_CR151","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02166.x","volume":"115","author":"EJ Meredith","year":"2005","unstructured":"Meredith EJ, Chamba A, Holder MJ, Barnes NM, Gordon J (2005) Close encounters of the monoamine kind: immune cells betray their nervous disposition. Immunology 115(3):289\u2013295. doi: 10.1111\/j.1365-2567.2005.02166.x","journal-title":"Immunology"},{"issue":"3","key":"2549_CR152","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3479","volume":"20","author":"R Torres-Rosas","year":"2014","unstructured":"Torres-Rosas R, Yehia G, Pena G, Mishra P, del Rocio Thompson-Bonilla M, Moreno-Eutimio MA, Arriaga-Pizano LA, Isibasi A, Ulloa L (2014) Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med 20(3):291\u2013295. doi: 10.1038\/nm.3479","journal-title":"Nat Med"},{"issue":"1","key":"2549_CR153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1474-8673.2003.00280.x","volume":"23","author":"F Mignini","year":"2003","unstructured":"Mignini F, Streccioni V, Amenta F (2003) Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol 23(1):1\u201325","journal-title":"Auton Autacoid Pharmacol"},{"key":"2549_CR154","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JP (2011) The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 29:707\u2013735. doi: 10.1146\/annurev-immunol-031210-101405","journal-title":"Annu Rev Immunol"},{"issue":"7435","key":"2549_CR155","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao W, Zhang SZ, Tang M, Zhang XH, Zhou Z, Yin YQ, Zhou QB, Huang YY, Liu YJ, Wawrousek E, Chen T, Li SB, Xu M, Zhou JN, Hu G, Zhou JW (2013) Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature 494(7435):90\u201394. doi: 10.1038\/nature11748","journal-title":"Nature"},{"issue":"8","key":"2549_CR156","doi-asserted-by":"publisher","first-page":"e85888","DOI":"10.1172\/jci.insight.85888","volume":"1","author":"PR Konkalmatt","year":"2016","unstructured":"Konkalmatt PR, Asico LD, Zhang Y, Yang Y, Drachenberg C, Zheng X, Han F, Jose PA, Armando I (2016) Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight 1(8):e85888. doi: 10.1172\/jci.insight.85888","journal-title":"JCI Insight"},{"issue":"6","key":"2549_CR157","doi-asserted-by":"publisher","first-page":"e38745","DOI":"10.1371\/journal.pone.0038745","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Cuevas S, Asico LD, Escano C, Yang Y, Pascua AM, Wang X, Jones JE, Grandy D, Eisner G, Jose PA, Armando I (2012) Deficient dopamine D2 receptor function causes renal inflammation independently of high blood pressure. PLoS One 7(6):e38745. doi: 10.1371\/journal.pone.0038745","journal-title":"PLoS One"},{"issue":"10","key":"2549_CR158","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.4049\/jimmunol.1203121","volume":"190","author":"H Gonzalez","year":"2013","unstructured":"Gonzalez H, Contreras F, Prado C, Elgueta D, Franz D, Bernales S, Pacheco R (2013) Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson\u2019s disease. J Immunol 190(10):5048\u20135056. doi: 10.4049\/jimmunol.1203121","journal-title":"J Immunol"},{"issue":"5","key":"2549_CR159","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00134-006-0084-y","volume":"32","author":"R Oberbeck","year":"2006","unstructured":"Oberbeck R, Schmitz D, Wilsenack K, Schuler M, Husain B, Schedlowski M, Exton MS (2006) Dopamine affects cellular immune functions during polymicrobial sepsis. Intensive Care Med 32(5):731\u2013739. doi: 10.1007\/s00134-006-0084-y","journal-title":"Intensive Care Med"},{"issue":"3","key":"2549_CR160","doi-asserted-by":"publisher","first-page":"e0151882","DOI":"10.1371\/journal.pone.0151882","volume":"11","author":"HD Lim","year":"2016","unstructured":"Lim HD, Kim MH, Lee CY, Namgung U (2016) Anti-Inflammatory effects of acupuncture stimulation via the vagus nerve. PLoS One 11(3):e0151882. doi: 10.1371\/journal.pone.0151882","journal-title":"PLoS One"},{"issue":"8","key":"2549_CR161","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","volume":"60","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60(8):1059\u20131064. doi: 10.1001\/archneur.60.8.1059","journal-title":"Arch Neurol"},{"issue":"6","key":"2549_CR162","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20682","volume":"58","author":"H Chen","year":"2005","unstructured":"Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ, Ascherio A (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson\u2019s disease. Ann Neurol 58(6):963\u2013967. doi: 10.1002\/ana.20682","journal-title":"Ann Neurol"},{"issue":"2","key":"2549_CR163","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","volume":"205","author":"E Esposito","year":"2007","unstructured":"Esposito E, Di Matteo V, Benigno A, Pierucci M, Crescimanno G, Di Giovanni G (2007) Non-steroidal anti-inflammatory drugs in Parkinson\u2019s disease. Exp Neurol 205(2):295\u2013312. doi: 10.1016\/j.expneurol.2007.02.008","journal-title":"Exp Neurol"},{"issue":"3","key":"2549_CR164","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.nbd.2006.08.016","volume":"24","author":"MT Armentero","year":"2006","unstructured":"Armentero MT, Levandis G, Nappi G, Bazzini E, Blandini F (2006) Peripheral inflammation and neuroprotection: systemic pretreatment with complete Freund\u2019s adjuvant reduces 6-hydroxydopamine toxicity in a rodent model of Parkinson\u2019s disease. Neurobiol Dis 24(3):492\u2013505. doi: 10.1016\/j.nbd.2006.08.016","journal-title":"Neurobiol Dis"},{"key":"2549_CR165","doi-asserted-by":"publisher","first-page":"393769","DOI":"10.4061\/2011\/393769","volume":"2011","author":"A Machado","year":"2011","unstructured":"Machado A, Herrera AJ, Venero JL, Santiago M, De Pablos RM, Villaran RF, Espinosa-Oliva AM, Arguelles S, Sarmiento M, Delgado-Cortes MJ, Maurino R, Cano J (2011) Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson\u2019s disease incidence. Parkinson\u2019s Dis 2011:393769. doi: 10.4061\/2011\/393769","journal-title":"Parkinson\u2019s Dis"},{"issue":"5","key":"2549_CR166","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC, Weishaupt JH, Danzer KM (2014) Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol 128(5):651\u2013663. doi: 10.1007\/s00401-014-1345-4","journal-title":"Acta Neuropathol"},{"issue":"13","key":"2549_CR167","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/mds.26437","volume":"30","author":"VS Fung","year":"2015","unstructured":"Fung VS, Kordower JH (2015) Parkinson\u2019s disease and prion disease: straining the comparison. Mov Disord 30(13):1727. doi: 10.1002\/mds.26437","journal-title":"Mov Disord"},{"issue":"6248","key":"2549_CR168","doi-asserted-by":"publisher","first-page":"1255555","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M (2015) NEURODEGENERATION. Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349(6248):1255555. doi: 10.1126\/science.1255555","journal-title":"Science"},{"issue":"1","key":"2549_CR169","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/mds.25373","volume":"28","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Brundin P (2013) Parkinson\u2019s disease and alpha synuclein: is Parkinson\u2019s disease a prion-like disorder? Mov Disord 28(1):31\u201340. doi: 10.1002\/mds.25373","journal-title":"Mov Disord"},{"issue":"2","key":"2549_CR170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24(2):197\u2013211","journal-title":"Neurobiol Aging"},{"issue":"31","key":"2549_CR171","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci USA 106(31):13010\u201313015. doi: 10.1073\/pnas.0903691106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2549_CR172","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, Stefanis L, Vekrellis K (2010) Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 30(20):6838\u20136851. doi: 10.1523\/JNEUROSCI.5699-09.2010","journal-title":"J Neurosci"},{"issue":"25","key":"2549_CR173","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 25(25):6016\u20136024. doi: 10.1523\/JNEUROSCI.0692-05.2005","journal-title":"J Neurosci"},{"key":"2549_CR174","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, Vanderburg CR, McLean PJ (2012) Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener 7:42. doi: 10.1186\/1750-1326-7-42","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2549_CR175","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","volume":"42","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, Cooper JM (2011) Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis 42(3):360\u2013367. doi: 10.1016\/j.nbd.2011.01.029","journal-title":"Neurobiol Dis"},{"issue":"12","key":"2549_CR176","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1074\/jbc.275.12.8812","volume":"275","author":"PJ McLean","year":"2000","unstructured":"McLean PJ, Kawamata H, Ribich S, Hyman BT (2000) Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson\u2019s disease-linked mutations. J Biol Chem 275(12):8812\u20138816","journal-title":"J Biol Chem"},{"issue":"45","key":"2549_CR177","doi-asserted-by":"publisher","first-page":"46363","DOI":"10.1074\/jbc.C400260200","volume":"279","author":"R Kayed","year":"2004","unstructured":"Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279(45):46363\u201346366. doi: 10.1074\/jbc.C400260200","journal-title":"J Biol Chem"},{"issue":"9","key":"2549_CR178","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","volume":"40","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee JH, Paik SR, Lee SJ (2008) Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein. Int J Biochem Cell Bio 40(9):1835\u20131849. doi: 10.1016\/j.biocel.2008.01.017","journal-title":"Int J Biochem Cell Bio"},{"key":"2549_CR179","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnana.2014.00159","volume":"8","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B (2014) Alpha-synuclein spreading in Parkinson\u2019s disease. Front Neuroanat 8:159. doi: 10.3389\/fnana.2014.00159","journal-title":"Front Neuroanat"},{"issue":"6","key":"2549_CR180","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","volume":"279","author":"IF Tsigelny","year":"2012","unstructured":"Tsigelny IF, Sharikov Y, Wrasidlo W, Gonzalez T, Desplats PA, Crews L, Spencer B, Masliah E (2012) Role of alpha-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J 279(6):1000\u20131013. doi: 10.1111\/j.1742-4658.2012.08489.x","journal-title":"FEBS J"},{"issue":"2","key":"2549_CR181","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI43366","volume":"121","author":"C Hansen","year":"2011","unstructured":"Hansen C, Angot E, Bergstrom AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P (2011) alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Investig 121(2):715\u2013725. doi: 10.1172\/JCI43366","journal-title":"J Clin Investig"},{"issue":"1","key":"2549_CR182","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, Meaney DF, Trojanowski JQ, Lee VM (2011) Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72(1):57\u201371. doi: 10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"issue":"1","key":"2549_CR183","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J (2006) Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J Neurochem 97(1):265\u2013279. doi: 10.1111\/j.1471-4159.2006.03731.x","journal-title":"J Neurochem"},{"key":"2549_CR184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(01)78001-7","volume":"78","author":"S Akira","year":"2001","unstructured":"Akira S (2001) Toll-like receptors and innate immunity. Adv Immunol 78:1\u201356","journal-title":"Adv Immunol"},{"issue":"3","key":"2549_CR185","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/glia.20928","volume":"58","author":"S Lehnardt","year":"2010","unstructured":"Lehnardt S (2010) Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 58(3):253\u2013263. doi: 10.1002\/glia.20928","journal-title":"Glia"},{"key":"2549_CR186","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12868-015-0192-0","volume":"16","author":"EH Rannikko","year":"2015","unstructured":"Rannikko EH, Weber SS, Kahle PJ (2015) Exogenous alpha-synuclein induces toll-like receptor 4 dependent inflammatory responses in astrocytes. BMC Neurosci 16:57. doi: 10.1186\/s12868-015-0192-0","journal-title":"BMC Neurosci"},{"issue":"3","key":"2549_CR187","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5607\/en.2016.25.3.113","volume":"25","author":"C Kim","year":"2016","unstructured":"Kim C, Lee HJ, Masliah E, Lee SJ (2016) Non-cell-autonomous Neurotoxicity of alpha-synuclein Through Microglial Toll-like Receptor 2. Exp Neurobiol 25(3):113\u2013119. doi: 10.5607\/en.2016.25.3.113","journal-title":"Exp Neurobiol"},{"issue":"2","key":"2549_CR188","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","volume":"179","author":"N Stefanova","year":"2011","unstructured":"Stefanova N, Fellner L, Reindl M, Masliah E, Poewe W, Wenning GK (2011) Toll-like receptor 4 promotes alpha-synuclein clearance and survival of nigral dopaminergic neurons. Am J Pathol 179(2):954\u2013963. doi: 10.1016\/j.ajpath.2011.04.013","journal-title":"Am J Pathol"},{"issue":"6","key":"2549_CR189","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J (2010) The inflammasomes. Cell 140(6):821\u2013832. doi: 10.1016\/j.cell.2010.01.040","journal-title":"Cell"},{"issue":"5","key":"2549_CR190","doi-asserted-by":"publisher","first-page":"C1100","DOI":"10.1152\/ajpcell.00494.2003","volume":"286","author":"JM Kahlenberg","year":"2004","unstructured":"Kahlenberg JM, Dubyak GR (2004) Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol Cell Physiol 286(5):C1100\u2013C1108. doi: 10.1152\/ajpcell.00494.2003","journal-title":"Am J Physiol Cell Physiol"},{"issue":"4","key":"2549_CR191","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.immuni.2007.03.008","volume":"26","author":"TD Kanneganti","year":"2007","unstructured":"Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26(4):433\u2013443. doi: 10.1016\/j.immuni.2007.03.008","journal-title":"Immunity"},{"issue":"8","key":"2549_CR192","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857\u2013865. doi: 10.1038\/ni.1636","journal-title":"Nat Immunol"},{"issue":"8","key":"2549_CR193","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9(8):847\u2013856. doi: 10.1038\/ni.1631","journal-title":"Nat Immunol"},{"issue":"26","key":"2549_CR194","doi-asserted-by":"publisher","first-page":"9035","DOI":"10.1073\/pnas.0803933105","volume":"105","author":"SL Cassel","year":"2008","unstructured":"Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105(26):9035\u20139040. doi: 10.1073\/pnas.0803933105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5876","key":"2549_CR195","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.1156995","volume":"320","author":"C Dostert","year":"2008","unstructured":"Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320(5876):674\u2013677. doi: 10.1126\/science.1156995","journal-title":"Science"},{"issue":"1","key":"2549_CR196","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M (2013) Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS One 8(1):e55375. doi: 10.1371\/journal.pone.0055375","journal-title":"PLoS One"},{"issue":"8","key":"2549_CR197","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.biocel.2013.05.037","volume":"45","author":"SJ Crampton","year":"2013","unstructured":"Crampton SJ, O\u2019Keeffe GW (2013) NF-kappaB: emerging roles in hippocampal development and function. Int J Biochem Cell Biol 45(8):1821\u20131824. doi: 10.1016\/j.biocel.2013.05.037","journal-title":"Int J Biochem Cell Biol"},{"issue":"Pt 9","key":"2549_CR198","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1093\/brain\/aws193","volume":"135","author":"C Baiguera","year":"2012","unstructured":"Baiguera C, Alghisi M, Pinna A, Bellucci A, De Luca MA, Frau L, Morelli M, Ingrassia R, Benarese M, Porrini V, Pellitteri M, Bertini G, Fabene PF, Sigala S, Spillantini MG, Liou HC, Spano PF, Pizzi M (2012) Late-onset Parkinsonism in NFkappaB\/c-Rel-deficient mice. Braina J Neurol 135(Pt 9):2750\u20132765. doi: 10.1093\/brain\/aws193","journal-title":"Braina J Neurol"},{"key":"2549_CR199","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fnmol.2015.00077","volume":"8","author":"RH Shih","year":"2015","unstructured":"Shih RH, Wang CY, Yang CM (2015) NF-kappaB signaling pathways in neurological inflammation: a mini review. Front Mol Neurosci 8:77. doi: 10.3389\/fnmol.2015.00077","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2549_CR200","doi-asserted-by":"publisher","first-page":"615","DOI":"10.4049\/jimmunol.0903480","volume":"185","author":"EJ Lee","year":"2010","unstructured":"Lee EJ, Woo MS, Moon PG, Baek MC, Choi IY, Kim WK, Junn E, Kim HS (2010) Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185(1):615\u2013623. doi: 10.4049\/jimmunol.0903480","journal-title":"J Immunol"},{"issue":"4","key":"2549_CR201","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/039463200902200405","volume":"22","author":"H Wilms","year":"2009","unstructured":"Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schafer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, Brandenburg LO, Deuschl G, Schreiber S, Kirik D, Lucius R (2009) Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. Int J Immunopathol Pharmacol 22(4):897\u2013909","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"4","key":"2549_CR202","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.celrep.2015.09.044","volume":"13","author":"C Kim","year":"2015","unstructured":"Kim C, Rockenstein E, Spencer B, Kim HK, Adame A, Trejo M, Stafa K, Lee HJ, Lee SJ, Masliah E (2015) Antagonizing neuronal toll-like receptor 2 prevents synucleinopathy by activating autophagy. Cell Rep 13(4):771\u2013782. doi: 10.1016\/j.celrep.2015.09.044","journal-title":"Cell Rep"},{"issue":"2","key":"2549_CR203","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","volume":"98","author":"G Wang","year":"2012","unstructured":"Wang G, Pan J, Chen SD (2012) Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson\u2019s disease. Prog Neurobiol 98(2):207\u2013221. doi: 10.1016\/j.pneurobio.2012.06.003","journal-title":"Prog Neurobiol"},{"key":"2549_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.062","author":"S Stagkourakis","year":"2016","unstructured":"Stagkourakis S, Kim H, Lyons DJ, Broberger C (2016) Dopamine autoreceptor regulation of a hypothalamic dopaminergic network. Cell Rep. doi: 10.1016\/j.celrep.2016.03.062","journal-title":"Cell Rep"},{"issue":"1","key":"2549_CR205","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","volume":"214","author":"M Politis","year":"2008","unstructured":"Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson\u2019s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214(1):112\u2013116. doi: 10.1016\/j.expneurol.2008.07.021","journal-title":"Exp Neurol"},{"key":"2549_CR206","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fpsyt.2015.00032","volume":"6","author":"X Du","year":"2015","unstructured":"Du X, Pang TY (2015) Is dysregulation of the HPA-Axis a core pathophysiology mediating co-morbid depression in neurodegenerative diseases? Front Psychiatry 6:32. doi: 10.3389\/fpsyt.2015.00032","journal-title":"Front Psychiatry"},{"issue":"3","key":"2549_CR207","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000343808","volume":"97","author":"C Seifried","year":"2013","unstructured":"Seifried C, Boehncke S, Heinzmann J, Baudrexel S, Weise L, Gasser T, Eggert K, Fogel W, Baas H, Badenhoop K, Steinmetz H, Hilker R (2013) Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson\u2019s disease. Neuroendocrinology 97(3):283\u2013290. doi: 10.1159\/000343808","journal-title":"Neuroendocrinology"},{"issue":"4","key":"2549_CR208","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA (2009) Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease. J Clin Endocrinol Metab 94(4):1223\u20131228. doi: 10.1210\/jc.2008-2543","journal-title":"J Clin Endocrinol Metab"},{"key":"2549_CR209","doi-asserted-by":"publisher","first-page":"31493","DOI":"10.1038\/srep31493","volume":"6","author":"VL Batalha","year":"2016","unstructured":"Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buee L, Muller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, Blum D, Lopes LV (2016) The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep 6:31493. doi: 10.1038\/srep31493","journal-title":"Sci Rep"},{"issue":"5","key":"2549_CR210","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.34.5.672","volume":"34","author":"F Javoy-Agid","year":"1984","unstructured":"Javoy-Agid F, Ruberg M, Pique L, Bertagna X, Taquet H, Studler JM, Cesselin F, Epelbaum J, Agid Y (1984) Biochemistry of the hypothalamus in Parkinson\u2019s disease. Neurology 34(5):672\u2013675","journal-title":"Neurology"},{"issue":"1","key":"2549_CR211","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","volume":"639","author":"K Shannak","year":"1994","unstructured":"Shannak K, Rajput A, Rozdilsky B, Kish S, Gilbert J, Hornykiewicz O (1994) Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson\u2019s disease and normal subjects. Brain Res 639(1):33\u201341","journal-title":"Brain Res"},{"issue":"3","key":"2549_CR212","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2007.09.004","volume":"29","author":"RY Moore","year":"2008","unstructured":"Moore RY, Whone AL, Brooks DJ (2008) Extrastriatal monoamine neuron function in Parkinson\u2019s disease: an 18F-dopa PET study. Neurobiol Dis 29(3):381\u2013390. doi: 10.1016\/j.nbd.2007.09.004","journal-title":"Neurobiol Dis"},{"issue":"3","key":"2549_CR213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1991.tb04666.x","volume":"83","author":"G Cusimano","year":"1991","unstructured":"Cusimano G, Capriani C, Bonifati V, Meco G (1991) Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Acta Neurol Scand 83(3):145\u2013150","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2549_CR214","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ana.410030207","volume":"3","author":"JW Langston","year":"1978","unstructured":"Langston JW, Forno LS (1978) The hypothalamus in Parkinson disease. Ann Neurol 3(2):129\u2013133. doi: 10.1002\/ana.410030207","journal-title":"Ann Neurol"},{"key":"2549_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2016.03.012","volume":"27","author":"VD Felice","year":"2016","unstructured":"Felice VD, Quigley EM, Sullivan AM, O\u2019Keeffe GW, O\u2019Mahony SM (2016) Microbiota-gut-brain signalling in Parkinson\u2019s disease: implications for non-motor symptoms. Parkinsonism Relat Disord 27:1\u20138. doi: 10.1016\/j.parkreldis.2016.03.012","journal-title":"Parkinsonism Relat Disord"},{"key":"2549_CR216","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-0897-4_9","volume":"817","author":"P Holzer","year":"2014","unstructured":"Holzer P, Farzi A (2014) Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 817:195\u2013219. doi: 10.1007\/978-1-4939-0897-4_9","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"2549_CR217","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1523\/JNEUROSCI.4373-15.2016","volume":"36","author":"JA Bayliss","year":"2016","unstructured":"Bayliss JA, Lemus MB, Stark R, Santos VV, Thompson A, Rees DJ, Galic S, Elsworth JD, Kemp BE, Davies JS, Andrews ZB (2016) Ghrelin-AMPK signaling mediates the neuroprotective effects of calorie restriction in Parkinson\u2019s disease. J Neurosci 36(10):3049\u20133063. doi: 10.1523\/JNEUROSCI.4373-15.2016","journal-title":"J Neurosci"},{"issue":"3","key":"2549_CR218","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/jnc.13576","volume":"137","author":"JA Bayliss","year":"2016","unstructured":"Bayliss JA, Lemus M, Santos VV, Deo M, Elsworth JD, Andrews ZB (2016) Acylated but not des-acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson\u2019s disease. J Neurochem 137(3):460\u2013471. doi: 10.1111\/jnc.13576","journal-title":"J Neurochem"},{"key":"2549_CR219","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.nbd.2016.07.022","volume":"95","author":"J Duarte-Neves","year":"2016","unstructured":"Duarte-Neves J, Pereira de Almeida L, Cavadas C (2016) Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases. Neurobiol Dis 95:210\u2013224. doi: 10.1016\/j.nbd.2016.07.022","journal-title":"Neurobiol Dis"},{"issue":"8","key":"2549_CR220","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1463-1326.2012.01592.x","volume":"14","author":"L Zhang","year":"2012","unstructured":"Zhang L, Nguyen AD, Lee IC, Yulyaningsih E, Riepler SJ, Stehrer B, Enriquez RF, Lin S, Shi YC, Baldock PA, Sainsbury A, Herzog H (2012) NPY modulates PYY function in the regulation of energy balance and glucose homeostasis. Diabetes Obes Metab 14(8):727\u2013736. doi: 10.1111\/j.1463-1326.2012.01592.x","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"2549_CR221","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.18632\/aging.100996","volume":"8","author":"M Ferreira-Marques","year":"2016","unstructured":"Ferreira-Marques M, Aveleira CA, Carmo-Silva S, Botelho M, Pereira de Almeida L, Cavadas C (2016) Caloric restriction stimulates autophagy in rat cortical neurons through neuropeptide Y and ghrelin receptors activation. Aging 8(7):1470\u20131484. doi: 10.18632\/aging.100996","journal-title":"Aging"},{"issue":"10","key":"2549_CR222","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.intimp.2011.05.006","volume":"11","author":"DS Arroyo","year":"2011","unstructured":"Arroyo DS, Soria JA, Gaviglio EA, Rodriguez-Galan MC, Iribarren P (2011) Toll-like receptors are key players in neurodegeneration. Int Immunopharmacol 11(10):1415\u20131421. doi: 10.1016\/j.intimp.2011.05.006","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"2549_CR223","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/S0002-8223(95)00269-3","volume":"95","author":"PL Beyer","year":"1995","unstructured":"Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson\u2019s disease. J Am Diet Assoc 95(9):979\u2013983. doi: 10.1016\/S0002-8223(95)00269-3","journal-title":"J Am Diet Assoc"},{"issue":"3","key":"2549_CR224","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.parkreldis.2011.10.016","volume":"18","author":"MA Marck van der","year":"2012","unstructured":"van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR, Overeem S, Munneke M (2012) Body mass index in Parkinson\u2019s disease: a meta-analysis. Parkinsonism Relat Disord 18(3):263\u2013267. doi: 10.1016\/j.parkreldis.2011.10.016","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"2549_CR225","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/ana.10577","volume":"53","author":"H Chen","year":"2003","unstructured":"Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson\u2019s disease. Ann Neurol 53(5):676\u2013679. doi: 10.1002\/ana.10577","journal-title":"Ann Neurol"},{"issue":"2","key":"2549_CR226","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1136\/jnnp-2016-314601","volume":"88","author":"E Pablo-Fernandez De","year":"2017","unstructured":"De Pablo-Fernandez E, Breen DP, Bouloux PM, Barker RA, Foltynie T, Warner TT (2017) Neuroendocrine abnormalities in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88(2):176\u2013185. doi: 10.1136\/jnnp-2016-314601","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 6","key":"2549_CR227","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/brain\/awm097","volume":"130","author":"TC Thannickal","year":"2007","unstructured":"Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson\u2019s disease. Brain J Neurol 130(Pt 6):1586\u20131595. doi: 10.1093\/brain\/awm097","journal-title":"Brain J Neurol"},{"issue":"4","key":"2549_CR228","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1212\/01.WNL.0000078194.53210.48","volume":"61","author":"X Drouot","year":"2003","unstructured":"Drouot X, Moutereau S, Nguyen JP, Lefaucheur JP, Creange A, Remy P, Goldenberg F, d\u2019Ortho MP (2003) Low levels of ventricular CSF orexin\/hypocretin in advanced PD. Neurology 61(4):540\u2013543","journal-title":"Neurology"},{"key":"2549_CR229","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","volume":"35","author":"JA Mohawk","year":"2012","unstructured":"Mohawk JA, Green CB, Takahashi JS (2012) Central and peripheral circadian clocks in mammals. Annu Rev Neurosci 35:445\u2013462. doi: 10.1146\/annurev-neuro-060909-153128","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"2549_CR230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00002826-200207000-00002","volume":"25","author":"B Bruguerolle","year":"2002","unstructured":"Bruguerolle B, Simon N (2002) Biologic rhythms and Parkinson\u2019s disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 25(4):194\u2013201","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"2549_CR231","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/mds.26509","volume":"31","author":"A Videnovic","year":"2016","unstructured":"Videnovic A, Willis GL (2016) Circadian system\u2014a novel diagnostic and therapeutic target in Parkinson\u2019s disease? Mov Disord 31(3):260\u2013269. doi: 10.1002\/mds.26509","journal-title":"Mov Disord"},{"key":"2549_CR232","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.expneurol.2012.08.018","volume":"243","author":"A Videnovic","year":"2013","unstructured":"Videnovic A, Golombek D (2013) Circadian and sleep disorders in Parkinson\u2019s disease. Exp Neurol 243:45\u201356. doi: 10.1016\/j.expneurol.2012.08.018","journal-title":"Exp Neurol"},{"issue":"1","key":"2549_CR233","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:DOOP.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol Adv Ophthalmol 108(1):17\u201340","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"issue":"12","key":"2549_CR234","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1111\/j.1460-9568.2005.04512.x","volume":"22","author":"K Sakamoto","year":"2005","unstructured":"Sakamoto K, Liu C, Kasamatsu M, Pozdeyev NV, Iuvone PM, Tosini G (2005) Dopamine regulates melanopsin mRNA expression in intrinsically photosensitive retinal ganglion cells. Eur J Neurosci 22(12):3129\u20133136. doi: 10.1111\/j.1460-9568.2005.04512.x","journal-title":"Eur J Neurosci"},{"issue":"4","key":"2549_CR235","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1017\/S0952523807070538","volume":"24","author":"R Dorenbos","year":"2007","unstructured":"Dorenbos R, Contini M, Hirasawa H, Gustincich S, Raviola E (2007) Expression of circadian clock genes in retinal dopaminergic cells. Vis Neurosci 24(4):573\u2013580. doi: 10.1017\/S0952523807070538","journal-title":"Vis Neurosci"},{"issue":"26","key":"2549_CR236","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.1073\/pnas.0503584102","volume":"102","author":"CA McClung","year":"2005","unstructured":"McClung CA, Sidiropoulou K, Vitaterna M, Takahashi JS, White FJ, Cooper DC, Nestler EJ (2005) Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proc Natl Acad Sci USA 102(26):9377\u20139381. doi: 10.1073\/pnas.0503584102","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"2549_CR237","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cub.2008.04.012","volume":"18","author":"G Hampp","year":"2008","unstructured":"Hampp G, Ripperger JA, Houben T, Schmutz I, Blex C, Perreau-Lenz S, Brunk I, Spanagel R, Ahnert-Hilger G, Meijer JH, Albrecht U (2008) Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol CB 18(9):678\u2013683. doi: 10.1016\/j.cub.2008.04.012","journal-title":"Curr Biol CB"},{"issue":"1","key":"2549_CR238","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1471-4159.2012.07857.x","volume":"123","author":"S Spencer","year":"2012","unstructured":"Spencer S, Torres-Altoro MI, Falcon E, Arey R, Marvin M, Goldberg M, Bibb JA, McClung CA (2012) A mutation in CLOCK leads to altered dopamine receptor function. J Neurochem 123(1):124\u2013134. doi: 10.1111\/j.1471-4159.2012.07857.x","journal-title":"J Neurochem"},{"issue":"4","key":"2549_CR239","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cell.2014.03.039","volume":"157","author":"S Chung","year":"2014","unstructured":"Chung S, Lee EJ, Yun S, Choe HK, Park SB, Son HJ, Kim KS, Dluzen DE, Lee I, Hwang O, Son GH, Kim K (2014) Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell 157(4):858\u2013868. doi: 10.1016\/j.cell.2014.03.039","journal-title":"Cell"},{"issue":"42","key":"2549_CR240","doi-asserted-by":"publisher","first-page":"14046","DOI":"10.1523\/JNEUROSCI.2128-10.2010","volume":"30","author":"S Hood","year":"2010","unstructured":"Hood S, Cassidy P, Cossette MP, Weigl Y, Verwey M, Robinson B, Stewart J, Amir S (2010) Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J Neurosci 30(42):14046\u201314058. doi: 10.1523\/JNEUROSCI.2128-10.2010","journal-title":"J Neurosci"},{"issue":"6","key":"2549_CR241","doi-asserted-by":"publisher","first-page":"R740","DOI":"10.1152\/ajpregu.00602.2011","volume":"302","author":"JD Glass","year":"2012","unstructured":"Glass JD, Brager AJ, Stowie AC, Prosser RA (2012) Cocaine modulates pathways for photic and nonphotic entrainment of the mammalian SCN circadian clock. Am J Physiol Regul Integr Comp Physiol 302(6):R740\u2013R750. doi: 10.1152\/ajpregu.00602.2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"2549_CR242","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1460-9568.2009.06976.x","volume":"30","author":"K Honma","year":"2009","unstructured":"Honma K, Honma S (2009) The SCN-independent clocks, methamphetamine and food restriction. Eur J Neurosci 30(9):1707\u20131717. doi: 10.1111\/j.1460-9568.2009.06976.x","journal-title":"Eur J Neurosci"},{"issue":"8 Suppl 3","key":"2549_CR243","first-page":"S2","volume":"63","author":"DB Rye","year":"2004","unstructured":"Rye DB (2004) The two faces of Eve: dopamine\u2019s modulation of wakefulness and sleep. Neurology 63(8 Suppl 3):S2\u2013S7","journal-title":"Neurology"},{"issue":"7","key":"2549_CR244","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11910-016-0664-3","volume":"16","author":"LM Trotti","year":"2016","unstructured":"Trotti LM, Karroum EG (2016) Melatonin for sleep disorders in patients with neurodegenerative diseases. Curr Neurol Neurosci Rep 16(7):63. doi: 10.1007\/s11910-016-0664-3","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"2549_CR245","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1016\/j.neurobiolaging.2011.10.015","volume":"33","author":"K Ono","year":"2012","unstructured":"Ono K, Mochizuki H, Ikeda T, Nihira T, Takasaki J, Teplow DB, Yamada M (2012) Effect of melatonin on alpha-synuclein self-assembly and cytotoxicity. Neurobiol Aging 33(9):2172\u20132185. doi: 10.1016\/j.neurobiolaging.2011.10.015","journal-title":"Neurobiol Aging"},{"issue":"3","key":"2549_CR246","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12640-012-9337-4","volume":"23","author":"SR Pandi-Perumal","year":"2013","unstructured":"Pandi-Perumal SR, BaHammam AS, Brown GM, Spence DW, Bharti VK, Kaur C, Hardeland R, Cardinali DP (2013) Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotox Res 23(3):267\u2013300. doi: 10.1007\/s12640-012-9337-4","journal-title":"Neurotox Res"},{"issue":"2","key":"2549_CR247","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12640-012-9350-7","volume":"23","author":"K Permpoonputtana","year":"2013","unstructured":"Permpoonputtana K, Govitrapong P (2013) The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines. Neurotox Res 23(2):189\u2013199. doi: 10.1007\/s12640-012-9350-7","journal-title":"Neurotox Res"},{"issue":"4","key":"2549_CR248","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic A, Noble C, Reid KJ, Peng J, Turek FW, Marconi A, Rademaker AW, Simuni T, Zadikoff C, Zee PC (2014) Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA neurology 71(4):463\u2013469. doi: 10.1001\/jamaneurol.2013.6239","journal-title":"JAMA neurology"},{"issue":"1","key":"2549_CR249","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","volume":"45","author":"NK Singhal","year":"2012","unstructured":"Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP (2012) Melatonin as a neuroprotective agent in the rodent models of Parkinson\u2019s disease: is it all set to irrefutable clinical translation? Mol Neurobiol 45(1):186\u2013199. doi: 10.1007\/s12035-011-8225-x","journal-title":"Mol Neurobiol"},{"issue":"2","key":"2549_CR250","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1600-079X.2012.00980.x","volume":"53","author":"JK Jeong","year":"2012","unstructured":"Jeong JK, Moon MH, Lee YJ, Seol JW, Park SY (2012) Melatonin-induced autophagy protects against human prion protein-mediated neurotoxicity. J Pineal Res 53(2):138\u2013146. doi: 10.1111\/j.1600-079X.2012.00980.x","journal-title":"J Pineal Res"},{"issue":"10","key":"2549_CR251","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.sleep.2015.06.018","volume":"16","author":"H Belaid","year":"2015","unstructured":"Belaid H, Adrien J, Karachi C, Hirsch EC, Francois C (2015) Effect of melatonin on sleep disorders in a monkey model of Parkinson\u2019s disease. Sleep Med 16(10):1245\u20131251. doi: 10.1016\/j.sleep.2015.06.018","journal-title":"Sleep Med"},{"key":"2549_CR252","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainres.2015.12.036","volume":"1633","author":"CH Carriere","year":"2016","unstructured":"Carriere CH, Kang NH, Niles LP (2016) Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson\u2019s disease. Brain Res 1633:115\u2013125. doi: 10.1016\/j.brainres.2015.12.036","journal-title":"Brain Res"},{"issue":"3","key":"2549_CR253","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/jpi.12212","volume":"58","author":"A Naskar","year":"2015","unstructured":"Naskar A, Prabhakar V, Singh R, Dutta D, Mohanakumar KP (2015) Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice. J Pineal Res 58(3):262\u2013274. doi: 10.1111\/jpi.12212","journal-title":"J Pineal Res"},{"key":"2549_CR254","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","volume":"1593","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, da Cunha C, Lima MM, Andreatini R, Vital MA (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats. Brain Res 1593:95\u2013105. doi: 10.1016\/j.brainres.2014.09.068","journal-title":"Brain Res"},{"issue":"5","key":"2549_CR255","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/mds.25870","volume":"29","author":"M Emre","year":"2014","unstructured":"Emre M, Ford PJ, Bilgic B, Uc EY (2014) Cognitive impairment and dementia in Parkinson\u2019s disease: practical issues and management. Mov Disord 29(5):663\u2013672. doi: 10.1002\/mds.25870","journal-title":"Mov Disord"},{"issue":"6","key":"2549_CR256","doi-asserted-by":"publisher","first-page":"e1001347","DOI":"10.1371\/journal.pbio.1001347","volume":"10","author":"S Gonzalez","year":"2012","unstructured":"Gonzalez S, Moreno-Delgado D, Moreno E, Perez-Capote K, Franco R, Mallol J, Cortes A, Casado V, Lluis C, Ortiz J, Ferre S, Canela E, McCormick PJ (2012) Circadian-related heteromerization of adrenergic and dopamine D(4) receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol 10(6):e1001347. doi: 10.1371\/journal.pbio.1001347","journal-title":"PLoS Biol"},{"issue":"2","key":"2549_CR257","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","volume":"26","author":"R Bordet","year":"2003","unstructured":"Bordet R, Devos D, Brique S, Touitou Y, Guieu JD, Libersa C, Destee A (2003) Study of circadian melatonin secretion pattern at different stages of Parkinson\u2019s disease. Clin Neuropharmacol 26(2):65\u201372","journal-title":"Clin Neuropharmacol"},{"issue":"3995","key":"2549_CR258","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1126\/science.173.3995.450","volume":"173","author":"GC Cotzias","year":"1971","unstructured":"Cotzias GC, Tang LC, Miller ST, Ginos JZ (1971) Melatonin and abnormal movements induced by l-dopa in mice. Science 173(3995):450\u2013452","journal-title":"Science"},{"issue":"16","key":"2549_CR259","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1073\/pnas.0510691103","volume":"103","author":"I Yujnovsky","year":"2006","unstructured":"Yujnovsky I, Hirayama J, Doi M, Borrelli E, Sassone-Corsi P (2006) Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proc Natl Acad Sci USA 103(16):6386\u20136391. doi: 10.1073\/pnas.0510691103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1\u20132","key":"2549_CR260","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jneuroim.2009.07.018","volume":"216","author":"R Pacheco","year":"2009","unstructured":"Pacheco R, Prado CE, Barrientos MJ, Bernales S (2009) Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 216(1\u20132):8\u201319. doi: 10.1016\/j.jneuroim.2009.07.018","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2549_CR261","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite M (2016) Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol 216(1):42\u201389. doi: 10.1111\/apha.12476","journal-title":"Acta Physiol"},{"issue":"5","key":"2549_CR262","doi-asserted-by":"publisher","first-page":"349","DOI":"10.14336\/AD.2015.0330","volume":"6","author":"C Rangel-Barajas","year":"2015","unstructured":"Rangel-Barajas C, Coronel I, Floran B (2015) Dopamine receptors and neurodegeneration. Aging Dis 6(5):349\u2013368. doi: 10.14336\/AD.2015.0330","journal-title":"Aging Dis"},{"issue":"6","key":"2549_CR263","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.sleep.2006.10.011","volume":"8","author":"PC Baier","year":"2007","unstructured":"Baier PC, Trenkwalder C (2007) Circadian variation in restless legs syndrome. Sleep Med 8(6):645\u2013650. doi: 10.1016\/j.sleep.2006.10.011","journal-title":"Sleep Med"},{"issue":"1","key":"2549_CR264","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smrv.2004.08.001","volume":"9","author":"B Claustrat","year":"2005","unstructured":"Claustrat B, Brun J, Chazot G (2005) The basic physiology and pathophysiology of melatonin. Sleep Med Rev 9(1):11\u201324. doi: 10.1016\/j.smrv.2004.08.001","journal-title":"Sleep Med Rev"},{"issue":"1","key":"2549_CR265","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02251135","volume":"3","author":"E Fertl","year":"1991","unstructured":"Fertl E, Auff E, Doppelbauer A, Waldhauser F (1991) Circadian secretion pattern of melatonin in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 3(1):41\u201347","journal-title":"J Neural Transm Park Dis Dement Sect"},{"issue":"5","key":"2549_CR266","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","volume":"71","author":"DP Breen","year":"2014","unstructured":"Breen DP, Vuono R, Nawarathna U, Fisher K, Shneerson JM, Reddy AB, Barker RA (2014) Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol 71(5):589\u2013595. doi: 10.1001\/jamaneurol.2014.65","journal-title":"JAMA Neurol"},{"issue":"4","key":"2549_CR267","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","volume":"254","author":"CA Medeiros","year":"2007","unstructured":"Medeiros CA, Carvalhedo de Bruin PF, Lopes LA, Magalhaes MC, de Lourdes Seabra M, de Bruin VM (2007) Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson\u2019s disease. A randomized, double blind, placebo-controlled study. J Neurol 254(4):459\u2013464. doi: 10.1007\/s00415-006-0390-x","journal-title":"J Neurol"},{"issue":"1","key":"2549_CR268","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1096\/fj.00-0129com","volume":"15","author":"F Dabbeni-Sala","year":"2001","unstructured":"Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P (2001) Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15(1):164\u2013170. doi: 10.1096\/fj.00-0129com","journal-title":"FASEB J"},{"issue":"5","key":"2549_CR269","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","volume":"6","author":"GA Dowling","year":"2005","unstructured":"Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ (2005) Melatonin for sleep disturbances in Parkinson\u2019s disease. Sleep Med 6(5):459\u2013466. doi: 10.1016\/j.sleep.2005.04.004","journal-title":"Sleep Med"},{"key":"2549_CR270","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1749-6632.2000.tb05402.x","volume":"917","author":"RJ Reiter","year":"2000","unstructured":"Reiter RJ, Calvo JR, Karbownik M, Qi W, Tan DX (2000) Melatonin and its relation to the immune system and inflammation. Ann N Y Acad Sci 917:376\u2013386","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"2549_CR271","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.bcp.2010.07.041","volume":"80","author":"F Radogna","year":"2010","unstructured":"Radogna F, Diederich M, Ghibelli L (2010) Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80(12):1844\u20131852. doi: 10.1016\/j.bcp.2010.07.041","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"2549_CR272","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1385\/ENDO:27:2:169","volume":"27","author":"JC Mayo","year":"2005","unstructured":"Mayo JC, Sainz RM, Tan DX, Antolin I, Rodriguez C, Reiter RJ (2005) Melatonin and Parkinson\u2019s disease. Endocrine 27(2):169\u2013178. doi: 10.1385\/ENDO:27:2:169","journal-title":"Endocrine"},{"issue":"6","key":"2549_CR273","first-page":"1063","volume":"37","author":"N Mohan","year":"1995","unstructured":"Mohan N, Sadeghi K, Reiter RJ, Meltz ML (1995) The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 37(6):1063\u20131070","journal-title":"Biochem Mol Biol Int"},{"issue":"10","key":"2549_CR274","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1006\/cbir.1996.0091","volume":"20","author":"JI Chuang","year":"1996","unstructured":"Chuang JI, Mohan N, Meltz ML, Reiter RJ (1996) Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 20(10):687\u2013692. doi: 10.1006\/cbir.1996.0091","journal-title":"Cell Biol Int"},{"issue":"6","key":"2549_CR275","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0008-6363(96)00030-2","volume":"31","author":"S Bertuglia","year":"1996","unstructured":"Bertuglia S, Marchiafava PL, Colantuoni A (1996) Melatonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31(6):947\u2013952","journal-title":"Cardiovasc Res"},{"key":"2549_CR276","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neuro.2015.08.008","volume":"50","author":"P Wongprayoon","year":"2015","unstructured":"Wongprayoon P, Govitrapong P (2015) Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line. Neurotoxicology 50:122\u2013130. doi: 10.1016\/j.neuro.2015.08.008","journal-title":"Neurotoxicology"},{"key":"2549_CR277","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pneurobio.2015.02.001","volume":"127\u2013128","author":"R Hardeland","year":"2015","unstructured":"Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR (2015) Melatonin and brain inflammaging. Prog Neurobiol 127\u2013128:46\u201363. doi: 10.1016\/j.pneurobio.2015.02.001","journal-title":"Prog Neurobiol"},{"issue":"1","key":"2549_CR278","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jpi.12194","volume":"58","author":"T Ali","year":"2015","unstructured":"Ali T, Badshah H, Kim TH, Kim MO (2015) Melatonin attenuates D-galactose-induced memory impairment, neuroinflammation and neurodegeneration via RAGE\/NF-K B\/JNK signaling pathway in aging mouse model. J Pineal Res 58(1):71\u201385. doi: 10.1111\/jpi.12194","journal-title":"J Pineal Res"},{"issue":"3","key":"2549_CR279","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.yfrne.2012.04.003","volume":"33","author":"MH Hagenauer","year":"2012","unstructured":"Hagenauer MH, Lee TM (2012) The neuroendocrine control of the circadian system: adolescent chronotype. Front Neuroendocrinol 33(3):211\u2013229. doi: 10.1016\/j.yfrne.2012.04.003","journal-title":"Front Neuroendocrinol"},{"issue":"7","key":"2549_CR280","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/mds.26592","volume":"31","author":"DP Breen","year":"2016","unstructured":"Breen DP, Nombela C, Vuono R, Jones PS, Fisher K, Burn DJ, Brooks DJ, Reddy AB, Rowe JB, Barker RA (2016) Hypothalamic volume loss is associated with reduced melatonin output in Parkinson\u2019s disease. Mov Disord 31(7):1062\u20131066. doi: 10.1002\/mds.26592","journal-title":"Mov Disord"},{"issue":"11","key":"2549_CR281","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in Peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324. doi: 10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"issue":"1","key":"2549_CR282","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-017-0158-z","volume":"12","author":"GD Manocha","year":"2017","unstructured":"Manocha GD, Floden AM, Puig KL, Nagamoto-Combs K, Scherzer CR, Combs CK (2017) Defining the contribution of neuroinflammation to Parkinson\u2019s disease in humanized immune system mice. Mol Neurodegener 12(1):17. doi: 10.1186\/s13024-017-0158-z","journal-title":"Mol Neurodegener"},{"issue":"2","key":"2549_CR283","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1089\/neu.2015.4361","volume":"34","author":"M Liu","year":"2017","unstructured":"Liu M, Bachstetter AD, Cass WA, Lifshitz J, Bing G (2017) Pioglitazone attenuates neuroinflammation and promotes dopaminergic neuronal survival in the nigrostriatal system of rats after diffuse brain injury. J Neurotrauma 34(2):414\u2013422. doi: 10.1089\/neu.2015.4361","journal-title":"J Neurotrauma"},{"issue":"10","key":"2549_CR284","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/mds.26311","volume":"30","author":"A Mendes","year":"2015","unstructured":"Mendes A, Goncalves A, Vila-Cha N, Moreira I, Fernandes J, Damasio J, Teixeira-Pinto A, Taipa R, Lima AB, Cavaco S (2015) Appendectomy may delay Parkinson\u2019s disease Onset. Mov Disord 30(10):1404\u20131407. doi: 10.1002\/mds.26311","journal-title":"Mov Disord"},{"issue":"12","key":"2549_CR285","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1002\/mds.26761","volume":"31","author":"E Svensson","year":"2016","unstructured":"Svensson E, Horvath-Puho E, Stokholm MG, Sorensen HT, Henderson VW, Borghammer P (2016) Appendectomy and risk of Parkinson\u2019s disease: a nationwide cohort study with more than 10\u00a0years of follow-up. Mov Disord 31(12):1918\u20131922. doi: 10.1002\/mds.26761","journal-title":"Mov Disord"},{"key":"2549_CR286","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. doi: 10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"issue":"Pt 6","key":"2549_CR287","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain J Neurol 128(Pt 6):1314\u20131322. doi: 10.1093\/brain\/awh445","journal-title":"Brain J Neurol"},{"issue":"4","key":"2549_CR288","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1468-1331.2003.00612.x","volume":"10","author":"I Rektorova","year":"2003","unstructured":"Rektorova I, Rektor I, Bares M, Dostal V, Ehler E, Fanfrdlova Z, Fiedler J, Klajblova H, Kulist\u2019ak P, Ressner P, Svatova J, Urbanek K, Veliskova J (2003) Pramipexole and pergolide in the treatment of depression in Parkinson\u2019s disease: a national multicentre prospective randomized study. Eur J Neurol 10(4):399\u2013406","journal-title":"Eur J Neurol"},{"issue":"5","key":"2549_CR289","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00415-006-0067-5","volume":"253","author":"P Barone","year":"2006","unstructured":"Barone P, Scarzella L, Marconi R, Antonini A, Morgante L, Bracco F, Zappia M, Musch B, Depression\/Parkinson Italian Study G (2006) Pramipexole versus sertraline in the treatment of depression in Parkinson\u2019s disease: a national multicenter parallel-group randomized study. J Neurol 253(5):601\u2013607. doi: 10.1007\/s00415-006-0067-5","journal-title":"J Neurol"},{"issue":"14","key":"2549_CR290","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","volume":"68","author":"R Pahwa","year":"2007","unstructured":"Pahwa R, Stacy MA, Factor SA, Lyons KE, Stocchi F, Hersh BP, Elmer LW, Truong DD, Earl NL, Investigators E-PAS (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68(14):1108\u20131115. doi: 10.1212\/01.wnl.0000258660.74391.c1","journal-title":"Neurology"},{"issue":"2\u20133","key":"2549_CR291","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000356531","volume":"21","author":"N Pessoa Rocha","year":"2014","unstructured":"Pessoa Rocha N, Reis HJ, Vanden Berghe P, Cirillo C (2014) Depression and cognitive impairment in Parkinson\u2019s disease: a role for inflammation and immunomodulation? NeuroImmunoModulation 21(2\u20133):88\u201394. doi: 10.1159\/000356531","journal-title":"NeuroImmunoModulation"},{"key":"2549_CR292","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O (2013) Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease\u2013associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 33:183\u2013189. doi: 10.1016\/j.bbi.2013.07.007","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2549_CR293","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","volume":"185","author":"YC Chung","year":"2010","unstructured":"Chung YC, Kim SR, Jin BK (2010) Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson\u2019s disease. J Immunol 185(2):1230\u20131237. doi: 10.4049\/jimmunol.1000208","journal-title":"J Immunol"},{"issue":"1\u20132","key":"2549_CR294","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/00207459009000510","volume":"51","author":"R Sandyk","year":"1990","unstructured":"Sandyk R (1990) Pineal melatonin functions and the depression of Parkinson\u2019s disease: a hypothesis. Int J Neurosci 51(1\u20132):73\u201377","journal-title":"Int J Neurosci"},{"issue":"Pt 11","key":"2549_CR295","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain J Neurol 130(Pt 11):2770\u20132788. doi: 10.1093\/brain\/awm056","journal-title":"Brain J Neurol"},{"issue":"10","key":"2549_CR296","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1212\/WNL.61.10.1418","volume":"61","author":"ML Fantini","year":"2003","unstructured":"Fantini ML, Gagnon JF, Filipini D, Montplaisir J (2003) The effects of pramipexole in REM sleep behavior disorder. Neurology 61(10):1418\u20131420","journal-title":"Neurology"},{"issue":"10","key":"2549_CR297","doi-asserted-by":"publisher","first-page":"e0138997","DOI":"10.1371\/journal.pone.0138997","volume":"10","author":"Y Hu","year":"2015","unstructured":"Hu Y, Yu SY, Zuo LJ, Piao YS, Cao CJ, Wang F, Chen ZJ, Du Y, Lian TH, Liu GF, Wang YJ, Chan P, Chen SD, Wang XM, Zhang W (2015) Investigation on abnormal iron metabolism and related inflammation in Parkinson disease patients with probable RBD. PLoS One 10(10):e0138997. doi: 10.1371\/journal.pone.0138997","journal-title":"PLoS One"},{"issue":"20","key":"2549_CR298","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1523\/JNEUROSCI.20-20-07760.2000","volume":"20","author":"P Bourgin","year":"2000","unstructured":"Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L (2000) Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20(20):7760\u20137765","journal-title":"J Neurosci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2549-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:33:13Z","timestamp":1602318793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2549-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,16]]},"references-count":298,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2549-2","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,16]]}}}